Matched phv,TOPMed Study,TOPMed Harmonized Variable,dbGap Variable Description,dbGap Variable Name,TOPMed Component ID,dbGap phs,dbGap phv,dbGap pht,dbGap pht Name,dbGap Study Name
phv00036469,FHS,pad_incident_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,pad_incident_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,pad_incident_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,pad_incident_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,pad_incident_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00078436,WHI,pad_incident_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,pad_incident_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,pad_incident_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193101,WHI,pad_incident_1,PAD diagnosis,PADDX,phs000200.v11.pht003406.v3.phv00193101.v3,phs000200.v12.p3,phv00193101.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193102,WHI,pad_incident_1,Ultrasonography or angiography,PADPLAQ,phs000200.v11.pht003406.v3.phv00193102.v3,phs000200.v12.p3,phv00193102.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193103,WHI,pad_incident_1,No Doppler pulse in vessels,PADABDOP,phs000200.v11.pht003406.v3.phv00193103.v3,phs000200.v12.p3,phv00193103.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193104,WHI,pad_incident_1,Positive exercise test,PADEXER,phs000200.v11.pht003406.v3.phv00193104.v3,phs000200.v12.p3,phv00193104.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193105,WHI,pad_incident_1,"Surgery, angioplasty or thromb",PADSURG,phs000200.v11.pht003406.v3.phv00193105.v3,phs000200.v12.p3,phv00193105.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193106,WHI,pad_incident_1,PAD Amputation of one or more toes,PADAMP,phs000200.v11.pht003406.v3.phv00193106.v3,phs000200.v12.p3,phv00193106.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193107,WHI,pad_incident_1,Exertional leg pain,PADLEG,phs000200.v11.pht003406.v3.phv00193107.v3,phs000200.v12.p3,phv00193107.v4.p3,pht003406.v4.p3,outc_cardio_rel4,Women's Health Initiative
phv00193190,WHI,pad_incident_1,PAD,PERIPH,phs000200.v11.pht003407.v3.phv00193190.v3,phs000200.v12.p3,phv00193190.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193191,WHI,pad_incident_1,Days enrollment to PAD,PERIPHDY,phs000200.v11.pht003407.v3.phv00193191.v3,phs000200.v12.p3,phv00193191.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,pad_incident_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,pad_incident_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00036469,FHS,angina_incident_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,angina_incident_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,angina_incident_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,angina_incident_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,angina_incident_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00078436,WHI,angina_incident_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,angina_incident_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,angina_incident_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193145,WHI,angina_incident_1,Angina,ANGINA,phs000200.v11.pht003407.v3.phv00193145.v3,phs000200.v12.p3,phv00193145.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193146,WHI,angina_incident_1,Days enrollment to Angina,ANGINADY,phs000200.v11.pht003407.v3.phv00193146.v3,phs000200.v12.p3,phv00193146.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,angina_incident_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,angina_incident_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00036469,FHS,mi_incident_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,mi_incident_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,mi_incident_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,mi_incident_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,mi_incident_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00078436,WHI,mi_incident_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,mi_incident_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,mi_incident_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193169,WHI,mi_incident_1,Clinical MI,MI,phs000200.v11.pht003407.v3.phv00193169.v3,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193170,WHI,mi_incident_1,Days enrollment to Clinical MI,MIDY,phs000200.v11.pht003407.v3.phv00193170.v3,phs000200.v12.p3,phv00193170.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,mi_incident_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,mi_incident_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00054697,FHS,cabg_incident_1,Date of cardiovascular procedure,procdate,phs000007.v30.pht000389.v10.phv00054697.v8,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,Framingham Cohort
phv00163410,FHS,cabg_incident_1,Coronary Artery Bypass Graft (CABG) - Number of vessels bypassed - PROCNUM = 141,vessel,phs000007.v30.pht000389.v10.phv00163410.v7,phs000007.v33.p14,phv00163410.v10.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,Framingham Cohort
phv00177930,FHS,cabg_incident_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,cabg_incident_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,cabg_incident_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00078436,WHI,cabg_incident_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,cabg_incident_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,cabg_incident_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193157,WHI,cabg_incident_1,CABG,CABG,phs000200.v11.pht003407.v3.phv00193157.v3,phs000200.v12.p3,phv00193157.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193158,WHI,cabg_incident_1,Days enrollment to CABG,CABGDY,phs000200.v11.pht003407.v3.phv00193158.v3,phs000200.v12.p3,phv00193158.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,cabg_incident_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,cabg_incident_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00036469,FHS,chd_death_probable_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,chd_death_probable_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,chd_death_probable_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,chd_death_probable_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,chd_death_probable_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00078436,WHI,chd_death_probable_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,chd_death_probable_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,chd_death_probable_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193498,WHI,chd_death_probable_1,Days enrollment to Death,DEATHDY,phs000200.v11.pht003407.v3.phv00193498.v3,phs000200.v12.p3,phv00193498.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,chd_death_probable_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,chd_death_probable_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193531,WHI,chd_death_probable_1,Death,DEATH,phs000200.v11.pht003409.v3.phv00193531.v2,phs000200.v12.p3,phv00193531.v3.p3,pht003409.v4.p3,outc_death_rel5,Women's Health Initiative
phv00193532,WHI,chd_death_probable_1,Cause of Death,DEATHCAUSE,phs000200.v11.pht003409.v3.phv00193532.v2,phs000200.v12.p3,phv00193532.v3.p3,pht003409.v4.p3,outc_death_rel5,Women's Health Initiative
phv00036469,FHS,chd_death_definite_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,chd_death_definite_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,chd_death_definite_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,chd_death_definite_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,chd_death_definite_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00078436,WHI,chd_death_definite_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,chd_death_definite_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,chd_death_definite_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193498,WHI,chd_death_definite_1,Days enrollment to Death,DEATHDY,phs000200.v11.pht003407.v3.phv00193498.v3,phs000200.v12.p3,phv00193498.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,chd_death_definite_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,chd_death_definite_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193531,WHI,chd_death_definite_1,Death,DEATH,phs000200.v11.pht003409.v3.phv00193531.v2,phs000200.v12.p3,phv00193531.v3.p3,pht003409.v4.p3,outc_death_rel5,Women's Health Initiative
phv00193532,WHI,chd_death_definite_1,Cause of Death,DEATHCAUSE,phs000200.v11.pht003409.v3.phv00193532.v2,phs000200.v12.p3,phv00193532.v3.p3,pht003409.v4.p3,outc_death_rel5,Women's Health Initiative
phv00177930,FHS,cad_followup_start_age_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00078437,WHI,cad_followup_start_age_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078436,WHI,coronary_angioplasty_incident_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,coronary_angioplasty_incident_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00192302,WHI,coronary_angioplasty_incident_1,Extension 2 MRC Participant,EXT2MRC,phs000200.v11.pht003395.v3.phv00192302.v3,phs000200.v12.p3,phv00192302.v3.p3,pht003395.v3.p3,ext_rel2,Women's Health Initiative
phv00193199,WHI,coronary_angioplasty_incident_1,PTCA,PTCA,phs000200.v11.pht003407.v3.phv00193199.v3,phs000200.v12.p3,phv00193199.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193200,WHI,coronary_angioplasty_incident_1,Days enrollment to PTCA,PTCADY,phs000200.v11.pht003407.v3.phv00193200.v3,phs000200.v12.p3,phv00193200.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193504,WHI,coronary_angioplasty_incident_1,Days enrollment to end of Ext1 followup,ENDEXT1DY,phs000200.v11.pht003407.v3.phv00193504.v3,phs000200.v12.p3,phv00193504.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00193505,WHI,coronary_angioplasty_incident_1,Days enrollment to end of followup,ENDFOLLOWDY,phs000200.v11.pht003407.v3.phv00193505.v3,phs000200.v12.p3,phv00193505.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,Women's Health Initiative
phv00100487,CHS,angina_prior_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100504,CHS,angina_prior_1,ANG MODIFIED BL STAT,ANBLMOD,phs000287.v6.pht001452.v1.phv00100504.v1,phs000287.v7.p1,phv00100504.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159608,COPDGene,angina_prior_1,Angina,Angina,phs000179.v5.pht002239.v4.phv00159608.v4,phs000179.v6.p2,phv00159608.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,angina_prior_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00036469,FHS,angina_prior_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,angina_prior_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,angina_prior_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,angina_prior_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,angina_prior_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00084442,MESA,angina_prior_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,angina_prior_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,angina_prior_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078507,WHI,angina_prior_1,F30 Days since randomization/enrollment,F30DAYS,phs000200.v11.pht000999.v6.phv00078507.v6,phs000200.v12.p3,phv00078507.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00078560,WHI,angina_prior_1,Angina ever,ANGINA,phs000200.v11.pht000999.v6.phv00078560.v6,phs000200.v12.p3,phv00078560.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00204712,ARIC,coronary_angioplasty_prior_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00208845,ARIC,coronary_angioplasty_prior_1,"[Invasive procedures]. Have you ever had surgery on your heart, or on the arteries of your neck or legs, excluding surgery for vericose veins? Q6 [Physical Examination Form. PHEA. Visit 1]",PHEA06,phs000280.v5.pht004143.v2.phv00208845.v1,phs000280.v8.p2,phv00208845.v2.p2,pht004143.v3.p2,PHEA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00208853,ARIC,coronary_angioplasty_prior_1,[Invasive procedures]. Have you ever had a balloon angioplasty on the arteries of your heart or legs? Q8 [Physical Examination Form. PHEA. Visit 1],PHEA08,phs000280.v5.pht004143.v2.phv00208853.v1,phs000280.v8.p2,phv00208853.v2.p2,pht004143.v3.p2,PHEA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00208854,ARIC,coronary_angioplasty_prior_1,[Invasive procedures]. [Probe for type of procedure]. Angioplasty of coronary artery(ies)? Q9a [Physical Examination Form. PHEA. Visit 1],PHEA09A,phs000280.v5.pht004143.v2.phv00208854.v1,phs000280.v8.p2,phv00208854.v2.p2,pht004143.v3.p2,PHEA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100322,CHS,coronary_angioplasty_prior_1,CORONARY ARTERY ANGIOPLASTY,CORART,phs000287.v6.pht001452.v1.phv00100322.v1,phs000287.v7.p1,phv00100322.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,coronary_angioplasty_prior_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159632,COPDGene,coronary_angioplasty_prior_1,Angioplasty or cardiac stents placed,Angioplasty,phs000179.v5.pht002239.v4.phv00159632.v4,phs000179.v6.p2,phv00159632.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,coronary_angioplasty_prior_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00127727,JHS,coronary_angioplasty_prior_1,"Q51. F. Invasive procedures. Ever had surgery on heart, arteries of neck or legs? [Visit 1] [Medical History Form, MHX]",MHXA51,phs000286.v5.pht001963.v1.phv00127727.v1,phs000286.v7.p2,phv00127727.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127731,JHS,coronary_angioplasty_prior_1,"Q52c. F. Invasive procedures. Have you had carotid endarterectomy? [Visit 1] [Medical History Form, MHX]",MHXA52C,phs000286.v5.pht001963.v1.phv00127731.v1,phs000286.v7.p2,phv00127731.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127733,JHS,coronary_angioplasty_prior_1,"Q52e1. F. Invasive procedures. Had other revascularization or bypass? [Visit 1] [Medical History Form, MHX]",MHXA52E1,phs000286.v5.pht001963.v1.phv00127733.v1,phs000286.v7.p2,phv00127733.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127737,JHS,coronary_angioplasty_prior_1,"Q54a. F. Invasive procedures. Ever had angioplasty of coronary arteries? [Visit 1] [Medical History Form, MHX]",MHXA54A,phs000286.v5.pht001963.v1.phv00127737.v1,phs000286.v7.p2,phv00127737.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127740,JHS,coronary_angioplasty_prior_1,"Q55a. F. Invasive procedures. Ever had heart catheterization? [Visit 1] [Medical History Form, MHX]",MHXA55A,phs000286.v5.pht001963.v1.phv00127740.v1,phs000286.v7.p2,phv00127740.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00084442,MESA,coronary_angioplasty_prior_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,coronary_angioplasty_prior_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,coronary_angioplasty_prior_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078507,WHI,coronary_angioplasty_prior_1,F30 Days since randomization/enrollment,F30DAYS,phs000200.v11.pht000999.v6.phv00078507.v6,phs000200.v12.p3,phv00078507.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00078536,WHI,coronary_angioplasty_prior_1,Angioplasty of coronary arteries ever,PTCA,phs000200.v11.pht000999.v6.phv00078536.v6,phs000200.v12.p3,phv00078536.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00204712,ARIC,cabg_prior_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00208845,ARIC,cabg_prior_1,"[Invasive procedures]. Have you ever had surgery on your heart, or on the arteries of your neck or legs, excluding surgery for vericose veins? Q6 [Physical Examination Form. PHEA. Visit 1]",PHEA06,phs000280.v5.pht004143.v2.phv00208845.v1,phs000280.v8.p2,phv00208845.v2.p2,pht004143.v3.p2,PHEA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00208846,ARIC,cabg_prior_1,"[Invasive procedures]. Have you ever had surgery on your heart, or on the arteries of your neck or legs, excluding surgery for vericose veins? Coronary bypass. Q7a [Physical Examination Form. PHEA. Visit 1]",PHEA07A,phs000280.v5.pht004143.v2.phv00208846.v1,phs000280.v8.p2,phv00208846.v2.p2,pht004143.v3.p2,PHEA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00208853,ARIC,cabg_prior_1,[Invasive procedures]. Have you ever had a balloon angioplasty on the arteries of your heart or legs? Q8 [Physical Examination Form. PHEA. Visit 1],PHEA08,phs000280.v5.pht004143.v2.phv00208853.v1,phs000280.v8.p2,phv00208853.v2.p2,pht004143.v3.p2,PHEA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,cabg_prior_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100785,CHS,cabg_prior_1,CORONARY BYPASS SURGERY AT BL,BPSSURBL,phs000287.v6.pht001464.v1.phv00100785.v1,phs000287.v7.p1,phv00100785.v1.p1,pht001464.v1.p1,EVENT_SUMMARY,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159631,COPDGene,cabg_prior_1,Coronary artery bypass surgery [CABG],CABG,phs000179.v5.pht002239.v4.phv00159631.v4,phs000179.v6.p2,phv00159631.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,cabg_prior_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00054697,FHS,cabg_prior_1,Date of cardiovascular procedure,procdate,phs000007.v30.pht000389.v10.phv00054697.v8,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,Framingham Cohort
phv00163410,FHS,cabg_prior_1,Coronary Artery Bypass Graft (CABG) - Number of vessels bypassed - PROCNUM = 141,vessel,phs000007.v30.pht000389.v10.phv00163410.v7,phs000007.v33.p14,phv00163410.v10.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,Framingham Cohort
phv00177930,FHS,cabg_prior_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,cabg_prior_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,cabg_prior_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00127727,JHS,cabg_prior_1,"Q51. F. Invasive procedures. Ever had surgery on heart, arteries of neck or legs? [Visit 1] [Medical History Form, MHX]",MHXA51,phs000286.v5.pht001963.v1.phv00127727.v1,phs000286.v7.p2,phv00127727.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127728,JHS,cabg_prior_1,"Q52a. F. Invasive procedures. Did you have a coronary bypass? [Visit 1] [Medical History Form, MHX]",MHXA52A,phs000286.v5.pht001963.v1.phv00127728.v1,phs000286.v7.p2,phv00127728.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127731,JHS,cabg_prior_1,"Q52c. F. Invasive procedures. Have you had carotid endarterectomy? [Visit 1] [Medical History Form, MHX]",MHXA52C,phs000286.v5.pht001963.v1.phv00127731.v1,phs000286.v7.p2,phv00127731.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127733,JHS,cabg_prior_1,"Q52e1. F. Invasive procedures. Had other revascularization or bypass? [Visit 1] [Medical History Form, MHX]",MHXA52E1,phs000286.v5.pht001963.v1.phv00127733.v1,phs000286.v7.p2,phv00127733.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00127740,JHS,cabg_prior_1,"Q55a. F. Invasive procedures. Ever had heart catheterization? [Visit 1] [Medical History Form, MHX]",MHXA55A,phs000286.v5.pht001963.v1.phv00127740.v1,phs000286.v7.p2,phv00127740.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00084442,MESA,cabg_prior_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,cabg_prior_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,cabg_prior_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078507,WHI,cabg_prior_1,F30 Days since randomization/enrollment,F30DAYS,phs000200.v11.pht000999.v6.phv00078507.v6,phs000200.v12.p3,phv00078507.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00078535,WHI,cabg_prior_1,Coronary bypass surgery ever,CABG,phs000200.v11.pht000999.v6.phv00078535.v6,phs000200.v12.p3,phv00078535.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00204712,ARIC,pad_prior_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204795,ARIC,pad_prior_1,"Peripheral artery disease visit 1, definition 2 - same for both genders [Cohort. Visit 1]",PAD02,phs000280.v5.pht004063.v2.phv00204795.v1,phs000280.v8.p2,phv00204795.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100330,CHS,pad_prior_1,LEG ARTERY BYPASS,ABTLEG,phs000287.v6.pht001452.v1.phv00100330.v1,phs000287.v7.p1,phv00100330.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100333,CHS,pad_prior_1,LOW EXTREM ANGIOPLASTY,EXTART,phs000287.v6.pht001452.v1.phv00100333.v1,phs000287.v7.p1,phv00100333.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,pad_prior_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100507,CHS,pad_prior_1,CLD MODIFIED BL STAT,CLBLMOD,phs000287.v6.pht001452.v1.phv00100507.v1,phs000287.v7.p1,phv00100507.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159618,COPDGene,pad_prior_1,Peripheral vascular disease,PeriphVascular,phs000179.v5.pht002239.v4.phv00159618.v4,phs000179.v6.p2,phv00159618.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,pad_prior_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00036469,FHS,pad_prior_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,pad_prior_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,pad_prior_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,pad_prior_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,pad_prior_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00124562,JHS,pad_prior_1,7. B. Measures. First brachial Doppler blood pressure (mm Hg) [Visit 1] [Ankle-Brachial Blood Pressure],ABBA7,phs000286.v5.pht001921.v1.phv00124562.v1,phs000286.v7.p2,phv00124562.v2.p2,pht001921.v2.p2,abba,Jackson Heart Study (JHS) Cohort
phv00124563,JHS,pad_prior_1,8. B. Measures. First right posterior tibia blood pressure (mm Hg) [Visit 1] [Ankle-Brachial Blood Pressure],ABBA8,phs000286.v5.pht001921.v1.phv00124563.v1,phs000286.v7.p2,phv00124563.v2.p2,pht001921.v2.p2,abba,Jackson Heart Study (JHS) Cohort
phv00124564,JHS,pad_prior_1,9. B. Measures. First left posterior tibia blood pressure (mm Hg) [Visit 1] [Ankle-Brachial Blood Pressure],ABBA9,phs000286.v5.pht001921.v1.phv00124564.v1,phs000286.v7.p2,phv00124564.v2.p2,pht001921.v2.p2,abba,Jackson Heart Study (JHS) Cohort
phv00124565,JHS,pad_prior_1,10. B. Measures. Second left posterior tibia [Visit 1] [Ankle-Brachial Blood Pressure],ABBA10,phs000286.v5.pht001921.v1.phv00124565.v1,phs000286.v7.p2,phv00124565.v2.p2,pht001921.v2.p2,abba,Jackson Heart Study (JHS) Cohort
phv00124566,JHS,pad_prior_1,11. B. Measures. Second right posterior tibia blood pressure (mm Hg) [Visit 1] [Ankle-Brachial Blood Pressure],ABBA11,phs000286.v5.pht001921.v1.phv00124566.v1,phs000286.v7.p2,phv00124566.v2.p2,pht001921.v2.p2,abba,Jackson Heart Study (JHS) Cohort
phv00124567,JHS,pad_prior_1,12. B. Measures. Second brachial blood pressure (mm Hg) [Visit 1] [Ankle-Brachial Blood Pressure],ABBA12,phs000286.v5.pht001921.v1.phv00124567.v1,phs000286.v7.p2,phv00124567.v2.p2,pht001921.v2.p2,abba,Jackson Heart Study (JHS) Cohort
phv00084442,MESA,pad_prior_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,pad_prior_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,pad_prior_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078507,WHI,pad_prior_1,F30 Days since randomization/enrollment,F30DAYS,phs000200.v11.pht000999.v6.phv00078507.v6,phs000200.v12.p3,phv00078507.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00078562,WHI,pad_prior_1,Peripheral arterial disease ever,PAD,phs000200.v11.pht000999.v6.phv00078562.v6,phs000200.v12.p3,phv00078562.v6.p3,pht000999.v6.p3,f30_rel2,Women's Health Initiative
phv00204705,ARIC,mi_prior_1,Prevalent MI from ECG or medical history [Cohort. Visit 1],PREVMI05,phs000280.v5.pht004063.v2.phv00204705.v1,phs000280.v8.p2,phv00204705.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204712,ARIC,mi_prior_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,mi_prior_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100508,CHS,mi_prior_1,MI MODIFIED BL STAT,MIBLMOD,phs000287.v6.pht001452.v1.phv00100508.v1,phs000287.v7.p1,phv00100508.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159615,COPDGene,mi_prior_1,Heart attack [MI],HeartAttack,phs000179.v5.pht002239.v4.phv00159615.v4,phs000179.v6.p2,phv00159615.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,mi_prior_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00036469,FHS,mi_prior_1,Event Number,EVENT,phs000007.v30.pht000309.v13.phv00036469.v12,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00036471,FHS,mi_prior_1,Date of Event,DATE,phs000007.v30.pht000309.v13.phv00036471.v12,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,Framingham Cohort
phv00177930,FHS,mi_prior_1,Age at Exam 1,age1,phs000007.v30.pht003099.v5.phv00177930.v5,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00190817,FHS,mi_prior_1,Cardiovascular Disease (CVD) status,cvd,phs000007.v30.pht003316.v7.phv00190817.v7,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00190823,FHS,mi_prior_1,Date of Cardiovascular Disease (CVD) status,cvddate,phs000007.v30.pht003316.v7.phv00190823.v7,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,Framingham Cohort
phv00084442,MESA,mi_prior_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,mi_prior_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,mi_prior_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078482,WHI,mi_prior_1,MI ever,MI,phs000200.v11.pht000998.v6.phv00078482.v6,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00204711,ARIC,annotated_sex_1,Sex (uncorrected from FTRA22) [Cohort. Visit 1],GENDER,phs000280.v5.pht004063.v2.phv00204711.v1,phs000280.v8.p2,phv00204711.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00115114,CARDIA,annotated_sex_1,SEX (VERIFIED AT EXAM 2),SEX,phs000285.v3.pht001645.v2.phv00115114.v2,phs000285.v3.p2,phv00115114.v2.p2,pht001645.v2.p2,B2REF,CARDIA Cohort
phv00100302,CHS,annotated_sex_1,GENDER,GEND01,phs000287.v6.pht001452.v1.phv00100302.v1,phs000287.v7.p1,phv00100302.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159571,COPDGene,annotated_sex_1,Gender,gender,phs000179.v5.pht002239.v4.phv00159571.v4,phs000179.v6.p2,phv00159571.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00177929,FHS,annotated_sex_1,Participant gender,sex,phs000007.v30.pht003099.v5.phv00177929.v5,phs000007.v33.p14,phv00177929.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00226279,HCHS_SOL,annotated_sex_1,"Gender (F=Female, M=Male)",GENDER,phs000810.v1.pht004715.v1.phv00226279.v1,phs000810.v2.p2,phv00226279.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00077315,WHI,annotated_sex_1,WHI dbGaP Consent Group,CONSENT,phs000200.v11.pht000982.v8.phv00077315.v8,phs000200.v12.p3,phv00077315.v8.p3,pht000982.v8.p3,WHI_Subject,Women's Health Initiative
phv00159573,COPDGene,hispanic_or_latino_1,Your ethnic background,ethnic,phs000179.v5.pht002239.v4.phv00159573.v4,phs000179.v6.p2,phv00159573.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226241,HCHS_SOL,hispanic_or_latino_1,Consent group,CONSENT,phs000810.v1.pht004713.v1.phv00226241.v1,phs000810.v2.p2,phv00226241.v2.p2,pht004713.v2.p2,HCHS_SOL_Cohort_Subject,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00078450,WHI,hispanic_or_latino_1,Racial or ethnic group,RACE,phs000200.v11.pht000998.v6.phv00078450.v6,phs000200.v12.p3,phv00078450.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00204710,ARIC,race_us_1,Race (from FTRA23) [Cohort. Visit 1],RACEGRP,phs000280.v5.pht004063.v2.phv00204710.v1,phs000280.v8.p2,phv00204710.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00115113,CARDIA,race_us_1,RACE (VERIFIED AT EXAM 2),RACE,phs000285.v3.pht001645.v2.phv00115113.v2,phs000285.v3.p2,phv00115113.v2.p2,pht001645.v2.p2,B2REF,CARDIA Cohort
phv00159572,COPDGene,race_us_1,Race,race,phs000179.v5.pht002239.v4.phv00159572.v4,phs000179.v6.p2,phv00159572.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226241,HCHS_SOL,race_us_1,Consent group,CONSENT,phs000810.v1.pht004713.v1.phv00226241.v1,phs000810.v2.p2,phv00226241.v2.p2,pht004713.v2.p2,HCHS_SOL_Cohort_Subject,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00124546,JHS,race_us_1,Consent group as determined by DAC,CONSENT,phs000286.v5.pht001920.v4.phv00124546.v3,phs000286.v7.p2,phv00124546.v4.p2,pht001920.v6.p2,JHS_Subject,Jackson Heart Study (JHS) Cohort
phv00078450,WHI,race_us_1,Racial or ethnic group,RACE,phs000200.v11.pht000998.v6.phv00078450.v6,phs000200.v12.p3,phv00078450.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079317,WHI,race_us_1,White,WHITE,phs000200.v11.pht001009.v6.phv00079317.v6,phs000200.v12.p3,phv00079317.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079318,WHI,race_us_1,"Black, African-American, or Negro",BLACK,phs000200.v11.pht001009.v6.phv00079318.v6,phs000200.v12.p3,phv00079318.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079319,WHI,race_us_1,American Indian or Alaskan Native,AMERINDIAN,phs000200.v11.pht001009.v6.phv00079319.v6,phs000200.v12.p3,phv00079319.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079320,WHI,race_us_1,Asian Indian,ASIAINDIAN,phs000200.v11.pht001009.v6.phv00079320.v6,phs000200.v12.p3,phv00079320.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079321,WHI,race_us_1,Chinese,CHINESE,phs000200.v11.pht001009.v6.phv00079321.v6,phs000200.v12.p3,phv00079321.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079322,WHI,race_us_1,Filipino,FILIPINO,phs000200.v11.pht001009.v6.phv00079322.v6,phs000200.v12.p3,phv00079322.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079323,WHI,race_us_1,Japanese,JAPANESE,phs000200.v11.pht001009.v6.phv00079323.v6,phs000200.v12.p3,phv00079323.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079324,WHI,race_us_1,Korean,KOREAN,phs000200.v11.pht001009.v6.phv00079324.v6,phs000200.v12.p3,phv00079324.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079325,WHI,race_us_1,Vietnamese,VIETNAMESE,phs000200.v11.pht001009.v6.phv00079325.v6,phs000200.v12.p3,phv00079325.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079326,WHI,race_us_1,Other Asian,OTHERASIAN,phs000200.v11.pht001009.v6.phv00079326.v6,phs000200.v12.p3,phv00079326.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079327,WHI,race_us_1,Native Hawaiian,HAWAIIAN,phs000200.v11.pht001009.v6.phv00079327.v6,phs000200.v12.p3,phv00079327.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079328,WHI,race_us_1,Guamanian or Chamorro,GUAMANIAN,phs000200.v11.pht001009.v6.phv00079328.v6,phs000200.v12.p3,phv00079328.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079329,WHI,race_us_1,Samoan,SAMOAN,phs000200.v11.pht001009.v6.phv00079329.v6,phs000200.v12.p3,phv00079329.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079330,WHI,race_us_1,Other Pacific Islander,OTHRPACISL,phs000200.v11.pht001009.v6.phv00079330.v6,phs000200.v12.p3,phv00079330.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00079331,WHI,race_us_1,Some other race,OTHERRACE,phs000200.v11.pht001009.v6.phv00079331.v6,phs000200.v12.p3,phv00079331.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00098580,ARIC,subcohort_1,Restriction on Use/Storage of DNA and Other,CONSENT,phs000280.v5.pht001440.v5.phv00098580.v4,phs000280.v8.p2,phv00098580.v5.p2,pht001440.v6.p2,ARIC_Subject,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112395,CARDIA,subcohort_1,Consent group,Consent,phs000285.v3.pht001554.v3.phv00112395.v2,phs000285.v3.p2,phv00112395.v2.p2,pht001554.v3.p2,CARDIA_Cohort_Subject,CARDIA Cohort
phv00100290,CHS,subcohort_1,COHORT,PERSTAT,phs000287.v6.pht001452.v1.phv00100290.v1,phs000287.v7.p1,phv00100290.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159560,COPDGene,subcohort_1,Consent group as determined by DAC,CONSENT,phs000179.v5.pht002237.v3.phv00159560.v3,phs000179.v6.p2,phv00159560.v3.p2,pht002237.v3.p2,COPDGene_Subject,Genetic Epidemiology of COPD (COPDGene)
phv00177928,FHS,subcohort_1,Framingham Heart Study cohort identifier,idtype,phs000007.v30.pht003099.v5.phv00177928.v5,phs000007.v33.p14,phv00177928.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00226241,HCHS_SOL,subcohort_1,Consent group,CONSENT,phs000810.v1.pht004713.v1.phv00226241.v1,phs000810.v2.p2,phv00226241.v2.p2,pht004713.v2.p2,HCHS_SOL_Cohort_Subject,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00124546,JHS,subcohort_1,Consent group as determined by DAC,CONSENT,phs000286.v5.pht001920.v4.phv00124546.v3,phs000286.v7.p2,phv00124546.v4.p2,pht001920.v6.p2,JHS_Subject,Jackson Heart Study (JHS) Cohort
phv00080424,WHI,subcohort_1,CT Participant,CTFLAG,phs000200.v11.pht001031.v6.phv00080424.v6,phs000200.v12.p3,phv00080424.v6.p3,pht001031.v7.p3,rand_rel2,Women's Health Initiative
phv00080425,WHI,subcohort_1,OS Participant,OSFLAG,phs000200.v11.pht001031.v6.phv00080425.v6,phs000200.v12.p3,phv00080425.v6.p3,pht001031.v7.p3,rand_rel2,Women's Health Initiative
phv00226254,HCHS_SOL,hispanic_subgroup_1,7-level re-classification of Hispanic/Latino Background,BKGRD1_C7,phs000810.v1.pht004715.v1.phv00226254.v1,phs000810.v2.p2,phv00226254.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00078450,WHI,hispanic_subgroup_1,Racial or ethnic group,RACE,phs000200.v11.pht000998.v6.phv00078450.v6,phs000200.v12.p3,phv00078450.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079316,WHI,hispanic_subgroup_1,Are you Spanish/Hispanic/Latino,SPANISH,phs000200.v11.pht001009.v6.phv00079316.v6,phs000200.v12.p3,phv00079316.v6.p3,pht001009.v6.p3,f41_rel1,Women's Health Initiative
phv00204813,ARIC,geographic_site_1,Recoded Center ID [Cohort. Visit 1],CENTERID,phs000280.v5.pht004063.v2.phv00204813.v1,phs000280.v8.p2,phv00204813.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00116398,CARDIA,geographic_site_1,CENTER FOR CARE PROJECT,CENTER_CARE,phs000285.v3.pht001700.v2.phv00116398.v2,phs000285.v3.p2,phv00116398.v2.p2,pht001700.v2.p2,CENTER,CARDIA Cohort
phv00100291,CHS,geographic_site_1,CHS CLINIC,CLINIC,phs000287.v6.pht001452.v1.phv00100291.v1,phs000287.v7.p1,phv00100291.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159569,COPDGene,geographic_site_1,De-identified site code,deid_center,phs000179.v5.pht002239.v4.phv00159569.v4,phs000179.v6.p2,phv00159569.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226256,HCHS_SOL,geographic_site_1,Center,CENTER,phs000810.v1.pht004715.v1.phv00226256.v1,phs000810.v2.p2,phv00226256.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00080435,WHI,geographic_site_1,U. S. Region,REGION,phs000200.v11.pht001031.v6.phv00080435.v6,phs000200.v12.p3,phv00080435.v6.p3,pht001031.v7.p3,rand_rel2,Women's Health Initiative
phv00203151,ARIC,height_baseline_1,"[Height and weight]. Standing height (to the nearest cm). Q1 [Anthropometry Form, ANTA. Visit 1]",ANTA01,phs000280.v5.pht004032.v2.phv00203151.v1,phs000280.v8.p2,phv00203151.v2.p2,pht004032.v3.p2,ANTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204712,ARIC,height_baseline_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,height_baseline_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113634,CARDIA,height_baseline_1,"PT'S HGT, CM. Q 1",A20HGT,phs000285.v3.pht001583.v2.phv00113634.v2,phs000285.v3.p2,phv00113634.v2.p2,pht001583.v2.p2,A4F20,CARDIA Cohort
phv00100382,CHS,height_baseline_1,STANDING HEIGHT - CM,STHT13,phs000287.v6.pht001452.v1.phv00100382.v1,phs000287.v7.p1,phv00100382.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,height_baseline_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159592,COPDGene,height_baseline_1,Height [cm],Height_CM,phs000179.v5.pht002239.v4.phv00159592.v4,phs000179.v6.p2,phv00159592.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,height_baseline_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226251,HCHS_SOL,height_baseline_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226281,HCHS_SOL,height_baseline_1,Height (corrected),HEIGHT,phs000810.v1.pht004715.v1.phv00226281.v1,phs000810.v2.p2,phv00226281.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00125860,JHS,height_baseline_1,A. Height and weight. 1: Standing height to nearest cm [Visit 1],antv1,phs000286.v5.pht001940.v1.phv00125860.v1,phs000286.v7.p2,phv00125860.v2.p2,pht001940.v2.p2,antv,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,height_baseline_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082683,MESA,height_baseline_1,HEIGHT (cm),htcm1,phs000209.v13.pht001111.v4.phv00082683.v1,phs000209.v13.p3,phv00082683.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,height_baseline_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084482,MESA,height_baseline_1,HEIGHT (cm),htcm1,phs000209.v13.pht001116.v10.phv00084482.v2,phs000209.v13.p3,phv00084482.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,height_baseline_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087078,MESA,height_baseline_1,HEIGHT (cm),htcmf,phs000209.v13.pht001121.v3.phv00087078.v1,phs000209.v13.p3,phv00087078.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,height_baseline_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,height_baseline_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079851,WHI,height_baseline_1,Visit year,F80VY,phs000200.v11.pht001019.v6.phv00079851.v6,phs000200.v12.p3,phv00079851.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079852,WHI,height_baseline_1,F80 Days since randomization/enrollment,F80DAYS,phs000200.v11.pht001019.v6.phv00079852.v6,phs000200.v12.p3,phv00079852.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079858,WHI,height_baseline_1,F80 Height cm,HEIGHTX,phs000200.v11.pht001019.v6.phv00079858.v6,phs000200.v12.p3,phv00079858.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00204712,ARIC,current_smoker_baseline_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207368,ARIC,current_smoker_baseline_1,Have you ever smoked cigarettes? Q28 [Home Interview. HOM. Visit 1],HOM28,phs000280.v5.pht004111.v2.phv00207368.v1,phs000280.v8.p2,phv00207368.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207370,ARIC,current_smoker_baseline_1,Do you now smoke cigarettes? Q30 [Home Interview. HOM. Visit 1],HOM30,phs000280.v5.pht004111.v2.phv00207370.v1,phs000280.v8.p2,phv00207370.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207372,ARIC,current_smoker_baseline_1,Number of cigarettes smoked per day. Q32 [Home Interview. HOM. Visit 1],HOM32,phs000280.v5.pht004111.v2.phv00207372.v1,phs000280.v8.p2,phv00207372.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,current_smoker_baseline_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113168,CARDIA,current_smoker_baseline_1,STILL SMOKES CIGARETTES REGULARLY? Q 2.01,A09SMKNW,phs000285.v3.pht001572.v2.phv00113168.v2,phs000285.v3.p2,phv00113168.v2.p2,pht001572.v2.p2,A4F09TOB,CARDIA Cohort
phv00113213,CARDIA,current_smoker_baseline_1,SUBJECT HAS SMOKED CIGARETTES. Q 2,A10CIGS,phs000285.v3.pht001573.v2.phv00113213.v2,phs000285.v3.p2,phv00113213.v2.p2,pht001573.v2.p2,A4F10,CARDIA Cohort
phv00098844,CHS,current_smoker_baseline_1,SMOKED IN LIFETIME,SMOKE101,phs000287.v6.pht001450.v1.phv00098844.v1,phs000287.v7.p1,phv00098844.v1.p1,pht001450.v1.p1,BASE1,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00098845,CHS,current_smoker_baseline_1,SMOKED CIGARETTES LAST 30 DAYS,SMOKE201,phs000287.v6.pht001450.v1.phv00098845.v1,phs000287.v7.p1,phv00098845.v1.p1,pht001450.v1.p1,BASE1,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,current_smoker_baseline_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00105143,CHS,current_smoker_baseline_1,SMOKED IN LIFETIME,SMOKE101,phs000287.v6.pht001490.v1.phv00105143.v1,phs000287.v7.p1,phv00105143.v1.p1,pht001490.v1.p1,YR5NEW,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00105144,CHS,current_smoker_baseline_1,SMOKED CIGARETTES LAST 30 DAYS,SMOKE201,phs000287.v6.pht001490.v1.phv00105144.v1,phs000287.v7.p1,phv00105144.v1.p1,pht001490.v1.p1,YR5NEW,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159636,COPDGene,current_smoker_baseline_1,How soon after waking do you smoke first cigarette,HowSoonSmoke,phs000179.v5.pht002239.v4.phv00159636.v4,phs000179.v6.p2,phv00159636.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159637,COPDGene,current_smoker_baseline_1,Smoke more during first 2 hours of day than rest of day,SmokeMore2hrs,phs000179.v5.pht002239.v4.phv00159637.v4,phs000179.v6.p2,phv00159637.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159640,COPDGene,current_smoker_baseline_1,Smoke when so ill you are in bed most of day,SmokeSickBed,phs000179.v5.pht002239.v4.phv00159640.v4,phs000179.v6.p2,phv00159640.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159749,COPDGene,current_smoker_baseline_1,Do you now smoke cigarettes [as of one month ago]?,SmokCigNow,phs000179.v5.pht002239.v4.phv00159749.v4,phs000179.v6.p2,phv00159749.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159750,COPDGene,current_smoker_baseline_1,How many cigarettes do you smoke per day now? [Cigarettes/day],CigPerDaySmokNow,phs000179.v5.pht002239.v4.phv00159750.v4,phs000179.v6.p2,phv00159750.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159754,COPDGene,current_smoker_baseline_1,How many cigarettes have you smoked in the past 24 hours [cigarettes],CigSmok24hrs,phs000179.v5.pht002239.v4.phv00159754.v4,phs000179.v6.p2,phv00159754.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159755,COPDGene,current_smoker_baseline_1,How many cigarettes have you smoked in the past 2 hours [cigarettes],CigSmok2hrs,phs000179.v5.pht002239.v4.phv00159755.v4,phs000179.v6.p2,phv00159755.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159756,COPDGene,current_smoker_baseline_1,How many cigarettes have you smoked in the past half hour [cigarettes],CigSmokHalfHr,phs000179.v5.pht002239.v4.phv00159756.v4,phs000179.v6.p2,phv00159756.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,current_smoker_baseline_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226251,HCHS_SOL,current_smoker_baseline_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258106,HCHS_SOL,current_smoker_baseline_1,Smoke at least 100 cigs in lifetime (TBEA1),TBEA1,phs000810.v1.pht004715.v1.phv00258106.v1,phs000810.v2.p2,phv00258106.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258107,HCHS_SOL,current_smoker_baseline_1,Present Smoking Status (TBEA3),TBEA3,phs000810.v1.pht004715.v1.phv00258107.v1,phs000810.v2.p2,phv00258107.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258108,HCHS_SOL,current_smoker_baseline_1,Daily: Cigs per Day - Present (TBEA4),TBEA4,phs000810.v1.pht004715.v1.phv00258108.v1,phs000810.v2.p2,phv00258108.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258110,HCHS_SOL,current_smoker_baseline_1,Some: Past 30 days - quit smoking 6 months or longer (TBEA5A),TBEA5A,phs000810.v1.pht004715.v1.phv00258110.v1,phs000810.v2.p2,phv00258110.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00128496,JHS,current_smoker_baseline_1,"Q1. Smoked at least 400 cigarettes in your lifetime [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA1,phs000286.v5.pht001977.v1.phv00128496.v1,phs000286.v7.p2,phv00128496.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00128498,JHS,current_smoker_baseline_1,"Q3. Do you now smoke cigarettes [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA3,phs000286.v5.pht001977.v1.phv00128498.v1,phs000286.v7.p2,phv00128498.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,current_smoker_baseline_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083243,MESA,current_smoker_baseline_1,SMOKED AT LEAST 100 CIGARETTES IN LIFETIME,evsmk1,phs000209.v13.pht001111.v4.phv00083243.v1,phs000209.v13.p3,phv00083243.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083245,MESA,current_smoker_baseline_1,CIGARETTES: SMOKED IN LAST 30 DAYS,cursmk1,phs000209.v13.pht001111.v4.phv00083245.v1,phs000209.v13.p3,phv00083245.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,current_smoker_baseline_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085570,MESA,current_smoker_baseline_1,SMOKED AT LEAST 100 CIGARETTES IN LIFETIME,evsmk1,phs000209.v13.pht001116.v10.phv00085570.v2,phs000209.v13.p3,phv00085570.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085572,MESA,current_smoker_baseline_1,CIGARETTES: SMOKED IN LAST 30 DAYS,cursmk1,phs000209.v13.pht001116.v10.phv00085572.v2,phs000209.v13.p3,phv00085572.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,current_smoker_baseline_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087252,MESA,current_smoker_baseline_1,SMOKED 100+ CIGARETTES IN LIFETIME,evsmkf,phs000209.v13.pht001121.v3.phv00087252.v1,phs000209.v13.p3,phv00087252.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087254,MESA,current_smoker_baseline_1,SMOKED CIGARETTES IN THE LAST 30 DAYS,cursmkf,phs000209.v13.pht001121.v3.phv00087254.v1,phs000209.v13.p3,phv00087254.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,current_smoker_baseline_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,current_smoker_baseline_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078773,WHI,current_smoker_baseline_1,F34 Days since randomization/enrollment,F34DAYS,phs000200.v11.pht001003.v6.phv00078773.v6,phs000200.v12.p3,phv00078773.v6.p3,pht001003.v6.p3,f34_rel2,Women's Health Initiative
phv00078774,WHI,current_smoker_baseline_1,Smoked at least 100 cigarettes ever,SMOKEVR,phs000200.v11.pht001003.v6.phv00078774.v6,phs000200.v12.p3,phv00078774.v6.p3,pht001003.v6.p3,f34_rel2,Women's Health Initiative
phv00078776,WHI,current_smoker_baseline_1,Smoke cigarettes now,SMOKNOW,phs000200.v11.pht001003.v6.phv00078776.v6,phs000200.v12.p3,phv00078776.v6.p3,pht001003.v6.p3,f34_rel2,Women's Health Initiative
phv00203154,ARIC,weight_baseline_1,"[Height and weight]. Weight (to the nearest lb). Q4 [Anthropometry Form, ANTA. Visit 1]",ANTA04,phs000280.v5.pht004032.v2.phv00203154.v1,phs000280.v8.p2,phv00203154.v2.p2,pht004032.v3.p2,ANTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204712,ARIC,weight_baseline_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,weight_baseline_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113635,CARDIA,weight_baseline_1,"PT'S WGT, LBS. Q 2",A20WGT,phs000285.v3.pht001583.v2.phv00113635.v2,phs000285.v3.p2,phv00113635.v2.p2,pht001583.v2.p2,A4F20,CARDIA Cohort
phv00100383,CHS,weight_baseline_1,WEIGHT - LBS,WEIGHT13,phs000287.v6.pht001452.v1.phv00100383.v1,phs000287.v7.p1,phv00100383.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,weight_baseline_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159591,COPDGene,weight_baseline_1,Weight [kg],Weight_KG,phs000179.v5.pht002239.v4.phv00159591.v4,phs000179.v6.p2,phv00159591.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,weight_baseline_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226251,HCHS_SOL,weight_baseline_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00253218,HCHS_SOL,weight_baseline_1,Weight (kg) (ANTA4),ANTA4,phs000810.v1.pht004715.v1.phv00253218.v1,phs000810.v2.p2,phv00253218.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00125861,JHS,weight_baseline_1,A. Height and weight. 2: Weight to nearest kilogram [Visit 1],antv2,phs000286.v5.pht001940.v1.phv00125861.v1,phs000286.v7.p2,phv00125861.v2.p2,pht001940.v2.p2,antv,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,weight_baseline_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082685,MESA,weight_baseline_1,WEIGHT (lbs),wtlb1,phs000209.v13.pht001111.v4.phv00082685.v1,phs000209.v13.p3,phv00082685.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,weight_baseline_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084484,MESA,weight_baseline_1,WEIGHT (lbs),wtlb1,phs000209.v13.pht001116.v10.phv00084484.v2,phs000209.v13.p3,phv00084484.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,weight_baseline_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087079,MESA,weight_baseline_1,WEIGHT (lbs),wtlbf,phs000209.v13.pht001121.v3.phv00087079.v1,phs000209.v13.p3,phv00087079.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,weight_baseline_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,weight_baseline_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079851,WHI,weight_baseline_1,Visit year,F80VY,phs000200.v11.pht001019.v6.phv00079851.v6,phs000200.v12.p3,phv00079851.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079852,WHI,weight_baseline_1,F80 Days since randomization/enrollment,F80DAYS,phs000200.v11.pht001019.v6.phv00079852.v6,phs000200.v12.p3,phv00079852.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079859,WHI,weight_baseline_1,F80 Weight kg,WEIGHTX,phs000200.v11.pht001019.v6.phv00079859.v6,phs000200.v12.p3,phv00079859.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00204712,ARIC,ever_smoker_baseline_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v5.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207368,ARIC,ever_smoker_baseline_1,Have you ever smoked cigarettes? Q28 [Home Interview. HOM. Visit 1],HOM28,phs000280.v5.pht004111.v2.phv00207368.v1,phs000280.v8.p2,phv00207368.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207369,ARIC,ever_smoker_baseline_1,How old were you when you first started regular cigarette smoking? Q29 [Home Interview. HOM. Visit 1],HOM29,phs000280.v5.pht004111.v2.phv00207369.v1,phs000280.v8.p2,phv00207369.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207370,ARIC,ever_smoker_baseline_1,Do you now smoke cigarettes? Q30 [Home Interview. HOM. Visit 1],HOM30,phs000280.v5.pht004111.v2.phv00207370.v1,phs000280.v8.p2,phv00207370.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207375,ARIC,ever_smoker_baseline_1,"On the average of the entire time you smoked, how many cigarettes did you usually smoke per day? Q35 [Home Interview. HOM. Visit 1]",HOM35,phs000280.v5.pht004111.v2.phv00207375.v1,phs000280.v8.p2,phv00207375.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207376,ARIC,ever_smoker_baseline_1,(Do/did) you inhale the cigarette smoke? Q36 [Home Interview. HOM. Visit 1],HOM36,phs000280.v5.pht004111.v2.phv00207376.v1,phs000280.v8.p2,phv00207376.v2.p2,pht004111.v3.p2,HOM,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,ever_smoker_baseline_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113213,CARDIA,ever_smoker_baseline_1,SUBJECT HAS SMOKED CIGARETTES. Q 2,A10CIGS,phs000285.v3.pht001573.v2.phv00113213.v2,phs000285.v3.p2,phv00113213.v2.p2,pht001573.v2.p2,A4F10,CARDIA Cohort
phv00098844,CHS,ever_smoker_baseline_1,SMOKED IN LIFETIME,SMOKE101,phs000287.v6.pht001450.v1.phv00098844.v1,phs000287.v7.p1,phv00098844.v1.p1,pht001450.v1.p1,BASE1,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00098845,CHS,ever_smoker_baseline_1,SMOKED CIGARETTES LAST 30 DAYS,SMOKE201,phs000287.v6.pht001450.v1.phv00098845.v1,phs000287.v7.p1,phv00098845.v1.p1,pht001450.v1.p1,BASE1,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00099157,CHS,ever_smoker_baseline_1,HOW OLD WHEN YOU STARTED TO SMOKE,SMKAGE08,phs000287.v6.pht001450.v1.phv00099157.v1,phs000287.v7.p1,phv00099157.v1.p1,pht001450.v1.p1,BASE1,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00099159,CHS,ever_smoker_baseline_1,HOW MANY DID YOU SMOKE PER DAY ON AVER (99=UNKNOWN),AMOUNT08,phs000287.v6.pht001450.v1.phv00099159.v1,phs000287.v7.p1,phv00099159.v1.p1,pht001450.v1.p1,BASE1,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,ever_smoker_baseline_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00105143,CHS,ever_smoker_baseline_1,SMOKED IN LIFETIME,SMOKE101,phs000287.v6.pht001490.v1.phv00105143.v1,phs000287.v7.p1,phv00105143.v1.p1,pht001490.v1.p1,YR5NEW,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00105144,CHS,ever_smoker_baseline_1,SMOKED CIGARETTES LAST 30 DAYS,SMOKE201,phs000287.v6.pht001490.v1.phv00105144.v1,phs000287.v7.p1,phv00105144.v1.p1,pht001490.v1.p1,YR5NEW,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00106198,CHS,ever_smoker_baseline_1,HOW OLD WHEN YOU STARTED TO SMOKE,SMKAGE58,phs000287.v6.pht001490.v1.phv00106198.v1,phs000287.v7.p1,phv00106198.v1.p1,pht001490.v1.p1,YR5NEW,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00106200,CHS,ever_smoker_baseline_1,HOW MANY DID YOU SMOKE PER DAY ON AVER.,AMOUNT58,phs000287.v6.pht001490.v1.phv00106200.v1,phs000287.v7.p1,phv00106200.v1.p1,pht001490.v1.p1,YR5NEW,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159636,COPDGene,ever_smoker_baseline_1,How soon after waking do you smoke first cigarette,HowSoonSmoke,phs000179.v5.pht002239.v4.phv00159636.v4,phs000179.v6.p2,phv00159636.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159637,COPDGene,ever_smoker_baseline_1,Smoke more during first 2 hours of day than rest of day,SmokeMore2hrs,phs000179.v5.pht002239.v4.phv00159637.v4,phs000179.v6.p2,phv00159637.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159638,COPDGene,ever_smoker_baseline_1,Which cigarette would you hate most to give up,CigHateGiveUp,phs000179.v5.pht002239.v4.phv00159638.v4,phs000179.v6.p2,phv00159638.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159639,COPDGene,ever_smoker_baseline_1,Do you find it hard to not smoke in forbidden places,FindHardNotSmoke,phs000179.v5.pht002239.v4.phv00159639.v4,phs000179.v6.p2,phv00159639.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159640,COPDGene,ever_smoker_baseline_1,Smoke when so ill you are in bed most of day,SmokeSickBed,phs000179.v5.pht002239.v4.phv00159640.v4,phs000179.v6.p2,phv00159640.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159641,COPDGene,ever_smoker_baseline_1,Do you now or did you smoke menthol cigarettes,SmokeMenthol,phs000179.v5.pht002239.v4.phv00159641.v4,phs000179.v6.p2,phv00159641.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159747,COPDGene,ever_smoker_baseline_1,Have you ever smoked cigarettes?,EverSmokedCig,phs000179.v5.pht002239.v4.phv00159747.v4,phs000179.v6.p2,phv00159747.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159748,COPDGene,ever_smoker_baseline_1,How old were you when you first started cigarette smoking? [Years old],SmokStartAge,phs000179.v5.pht002239.v4.phv00159748.v4,phs000179.v6.p2,phv00159748.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159749,COPDGene,ever_smoker_baseline_1,Do you now smoke cigarettes [as of one month ago]?,SmokCigNow,phs000179.v5.pht002239.v4.phv00159749.v4,phs000179.v6.p2,phv00159749.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159750,COPDGene,ever_smoker_baseline_1,How many cigarettes do you smoke per day now? [Cigarettes/day],CigPerDaySmokNow,phs000179.v5.pht002239.v4.phv00159750.v4,phs000179.v6.p2,phv00159750.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159752,COPDGene,ever_smoker_baseline_1,Average for entire time how many cigarettes smoked per day [cigarettes/day],CigPerDaySmokAvg,phs000179.v5.pht002239.v4.phv00159752.v4,phs000179.v6.p2,phv00159752.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159754,COPDGene,ever_smoker_baseline_1,How many cigarettes have you smoked in the past 24 hours [cigarettes],CigSmok24hrs,phs000179.v5.pht002239.v4.phv00159754.v4,phs000179.v6.p2,phv00159754.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159755,COPDGene,ever_smoker_baseline_1,How many cigarettes have you smoked in the past 2 hours [cigarettes],CigSmok2hrs,phs000179.v5.pht002239.v4.phv00159755.v4,phs000179.v6.p2,phv00159755.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159756,COPDGene,ever_smoker_baseline_1,How many cigarettes have you smoked in the past half hour [cigarettes],CigSmokHalfHr,phs000179.v5.pht002239.v4.phv00159756.v4,phs000179.v6.p2,phv00159756.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,ever_smoker_baseline_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00169388,COPDGene,ever_smoker_baseline_1,Duration of smoking [yrs],Duration_Smoking,phs000179.v5.pht002239.v4.phv00169388.v3,phs000179.v6.p2,phv00169388.v3.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226251,HCHS_SOL,ever_smoker_baseline_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258106,HCHS_SOL,ever_smoker_baseline_1,Smoke at least 100 cigs in lifetime (TBEA1),TBEA1,phs000810.v1.pht004715.v1.phv00258106.v1,phs000810.v2.p2,phv00258106.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258107,HCHS_SOL,ever_smoker_baseline_1,Present Smoking Status (TBEA3),TBEA3,phs000810.v1.pht004715.v1.phv00258107.v1,phs000810.v2.p2,phv00258107.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258108,HCHS_SOL,ever_smoker_baseline_1,Daily: Cigs per Day - Present (TBEA4),TBEA4,phs000810.v1.pht004715.v1.phv00258108.v1,phs000810.v2.p2,phv00258108.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258110,HCHS_SOL,ever_smoker_baseline_1,Some: Past 30 days - quit smoking 6 months or longer (TBEA5A),TBEA5A,phs000810.v1.pht004715.v1.phv00258110.v1,phs000810.v2.p2,phv00258110.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00128496,JHS,ever_smoker_baseline_1,"Q1. Smoked at least 400 cigarettes in your lifetime [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA1,phs000286.v5.pht001977.v1.phv00128496.v1,phs000286.v7.p2,phv00128496.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00128498,JHS,ever_smoker_baseline_1,"Q3. Do you now smoke cigarettes [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA3,phs000286.v5.pht001977.v1.phv00128498.v1,phs000286.v7.p2,phv00128498.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00128502,JHS,ever_smoker_baseline_1,"Q6. Do you smoke more frequently during the first few hours after awakening than during the rest of the day? [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA6,phs000286.v5.pht001977.v1.phv00128502.v1,phs000286.v7.p2,phv00128502.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00128503,JHS,ever_smoker_baseline_1,"Q7. How soon after you wake up do you smoke your first cigarette? [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA7,phs000286.v5.pht001977.v1.phv00128503.v1,phs000286.v7.p2,phv00128503.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00128506,JHS,ever_smoker_baseline_1,"Q10. Do you smoke if you are so ill that you are in bed most of the day? [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA10,phs000286.v5.pht001977.v1.phv00128506.v1,phs000286.v7.p2,phv00128506.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00128507,JHS,ever_smoker_baseline_1,"Q11. On the average for the entire time you have smoked, how many cigarettes did you smoke usually per day? [Visit 1] [Health Practices: Tobacco Use, TOB]",TOBA11,phs000286.v5.pht001977.v1.phv00128507.v1,phs000286.v7.p2,phv00128507.v2.p2,pht001977.v2.p2,toba,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,ever_smoker_baseline_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083243,MESA,ever_smoker_baseline_1,SMOKED AT LEAST 100 CIGARETTES IN LIFETIME,evsmk1,phs000209.v13.pht001111.v4.phv00083243.v1,phs000209.v13.p3,phv00083243.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083245,MESA,ever_smoker_baseline_1,CIGARETTES: SMOKED IN LAST 30 DAYS,cursmk1,phs000209.v13.pht001111.v4.phv00083245.v1,phs000209.v13.p3,phv00083245.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083247,MESA,ever_smoker_baseline_1,CIGARETTES: AVERAGE # SMOKED PER DAY,cigsday1,phs000209.v13.pht001111.v4.phv00083247.v1,phs000209.v13.p3,phv00083247.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,ever_smoker_baseline_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085570,MESA,ever_smoker_baseline_1,SMOKED AT LEAST 100 CIGARETTES IN LIFETIME,evsmk1,phs000209.v13.pht001116.v10.phv00085570.v2,phs000209.v13.p3,phv00085570.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085572,MESA,ever_smoker_baseline_1,CIGARETTES: SMOKED IN LAST 30 DAYS,cursmk1,phs000209.v13.pht001116.v10.phv00085572.v2,phs000209.v13.p3,phv00085572.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085574,MESA,ever_smoker_baseline_1,CIGARETTES: AVERAGE # SMOKED PER DAY,cigsday1,phs000209.v13.pht001116.v10.phv00085574.v2,phs000209.v13.p3,phv00085574.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,ever_smoker_baseline_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087252,MESA,ever_smoker_baseline_1,SMOKED 100+ CIGARETTES IN LIFETIME,evsmkf,phs000209.v13.pht001121.v3.phv00087252.v1,phs000209.v13.p3,phv00087252.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087254,MESA,ever_smoker_baseline_1,SMOKED CIGARETTES IN THE LAST 30 DAYS,cursmkf,phs000209.v13.pht001121.v3.phv00087254.v1,phs000209.v13.p3,phv00087254.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087256,MESA,ever_smoker_baseline_1,AVERAGE NUMBER OF CIGARETTES SMOKED PER DAY,cigsdayf,phs000209.v13.pht001121.v3.phv00087256.v1,phs000209.v13.p3,phv00087256.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,ever_smoker_baseline_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,ever_smoker_baseline_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078773,WHI,ever_smoker_baseline_1,F34 Days since randomization/enrollment,F34DAYS,phs000200.v11.pht001003.v6.phv00078773.v6,phs000200.v12.p3,phv00078773.v6.p3,pht001003.v6.p3,f34_rel2,Women's Health Initiative
phv00078774,WHI,ever_smoker_baseline_1,Smoked at least 100 cigarettes ever,SMOKEVR,phs000200.v11.pht001003.v6.phv00078774.v6,phs000200.v12.p3,phv00078774.v6.p3,pht001003.v6.p3,f34_rel2,Women's Health Initiative
phv00298019,ARIC,sleep_duration_1,F. Sleep. Q21. Hours of sleep in past month [Respiratory Symptoms Form. RSE. Visit 5],RSE21,phs000280.v5.pht006479.v1.phv00298019.v1,phs000280.v8.p2,phv00298019.v2.p2,pht006479.v2.p2,RSE,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00120534,CARDIA,sleep_duration_1,PAST MONTH AVG SLEEPING HOURS. Q 7,F67SLPHR,phs000285.v3.pht001839.v2.phv00120534.v2,phs000285.v3.p2,phv00120534.v2.p2,pht001839.v2.p2,F1F67,CARDIA Cohort
phv00120748,CARDIA,sleep_duration_1,CALCULATED AGE AT EXAM 6,EX6_AGE,phs000285.v3.pht001851.v2.phv00120748.v2,phs000285.v3.p2,phv00120748.v2.p2,pht001851.v2.p2,F1REF,CARDIA Cohort
phv00100694,CHS,sleep_duration_1,Age = StdyDtqa - DOB,AGE_S1,phs000287.v6.pht001460.v1.phv00100694.v1,phs000287.v7.p1,phv00100694.v1.p1,pht001460.v1.p1,CHS_SHHS1_15K,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100712,CHS,sleep_duration_1,How many hours of sleep do you usually get at night (or your main sleep period) on weekdays or workdays?,HRSWD02,phs000287.v6.pht001460.v1.phv00100712.v1,phs000287.v7.p1,phv00100712.v1.p1,pht001460.v1.p1,CHS_SHHS1_15K,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,sleep_duration_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258046,HCHS_SOL,sleep_duration_1,Average sleep duration (hours),SLPDUR,phs000810.v1.pht004715.v1.phv00258046.v1,phs000810.v2.p2,phv00258046.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127678,JHS,sleep_duration_1,"Q7. A. Sleep. During the past month, excluding naps, how many hours of actual sleep did you get at night (or day, if you work at night) on average (Hours)? [Visit 1] [Medical History Form, MHX]",MHXA7,phs000286.v5.pht001963.v1.phv00127678.v1,phs000286.v7.p2,phv00127678.v2.p2,pht001963.v2.p2,mhxa,Jackson Heart Study (JHS) Cohort
phv00086727,MESA,sleep_duration_1,AGE AT EXAM 4,age4c,phs000209.v13.pht001120.v10.phv00086727.v3,phs000209.v13.p3,phv00086727.v3.p3,pht001120.v10.p3,MESA_Exam4Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087048,MESA,sleep_duration_1,NIGHT SLEEP HOURS ON WEEKDAY OR WORKDAY,slpwkhr4,phs000209.v13.pht001120.v10.phv00087048.v2,phs000209.v13.p3,phv00087048.v2.p3,pht001120.v10.p3,MESA_Exam4Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,sleep_duration_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,sleep_duration_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078869,WHI,sleep_duration_1,Visit year,F37VY,phs000200.v11.pht001005.v6.phv00078869.v6,phs000200.v12.p3,phv00078869.v6.p3,pht001005.v6.p3,f37_rel1,Women's Health Initiative
phv00078870,WHI,sleep_duration_1,F37 Days since randomization/enrollment,F37DAYS,phs000200.v11.pht001005.v6.phv00078870.v6,phs000200.v12.p3,phv00078870.v6.p3,pht001005.v6.p3,f37_rel1,Women's Health Initiative
phv00079041,WHI,sleep_duration_1,How many hours of sleep,HRSSLP,phs000200.v11.pht001005.v6.phv00079041.v6,phs000200.v12.p3,phv00079041.v6.p3,pht001005.v6.p3,f37_rel1,Women's Health Initiative
phv00204712,ARIC,total_cholesterol_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204735,ARIC,total_cholesterol_1,Total cholesterol in SI units [Cohort. Visit 1],TCHSIU01,phs000280.v4.pht004063.v2.phv00204735.v1,phs000280.v8.p2,phv00204735.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,total_cholesterol_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113700,CARDIA,total_cholesterol_1,TOTAL CHOLESTEROL (MG/DL),AL1CHOL,phs000285.v3.pht001588.v2.phv00113700.v2,phs000285.v3.p2,phv00113700.v2.p2,pht001588.v2.p2,A4LIP,CARDIA Cohort
phv00100487,CHS,total_cholesterol_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100491,CHS,total_cholesterol_1,Adjusted Cholesterol (mg/dl),CHOLADJ,phs000287.v6.pht001452.v1.phv00100491.v1,phs000287.v7.p1,phv00100491.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,total_cholesterol_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00253238,HCHS_SOL,total_cholesterol_1,Total cholesterol (mg/dL) (LABA66),LABA66,phs000810.v1.pht004715.v1.phv00253238.v1,phs000810.v2.p2,phv00253238.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00125927,JHS,total_cholesterol_1,Chr: total cholesterol - mg/dL [Visit 1],CHR,phs000286.v5.pht001945.v1.phv00125927.v1,phs000286.v7.p2,phv00125927.v2.p2,pht001945.v2.p2,cena,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,total_cholesterol_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082956,MESA,total_cholesterol_1,TOTAL CHOLESTEROL (mg/dl),chol1,phs000209.v13.pht001111.v4.phv00082956.v1,phs000209.v13.p3,phv00082956.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,total_cholesterol_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084974,MESA,total_cholesterol_1,TOTAL CHOLESTEROL (mg/dl),chol1,phs000209.v13.pht001116.v10.phv00084974.v2,phs000209.v13.p3,phv00084974.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,total_cholesterol_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087100,MESA,total_cholesterol_1,TOTAL CHOLESTEROL (mg/dl),cholf,phs000209.v13.pht001121.v3.phv00087100.v1,phs000209.v13.p3,phv00087100.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,fasting_lipids_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204732,ARIC,fasting_lipids_1,Fasting time of 8 hours or more [Cohort. Visit 1],FAST0802,phs000280.v4.pht004063.v2.phv00204732.v1,phs000280.v8.p2,phv00204732.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,fasting_lipids_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112661,CARDIA,fasting_lipids_1,12 HR FAST BEFORE BLOOD DRAWN,A05FAST,phs000285.v3.pht001563.v2.phv00112661.v2,phs000285.v3.p2,phv00112661.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00099923,CHS,fasting_lipids_1,HOURS SINCE LAST ATE OR DRANK,FAST30,phs000287.v6.pht001451.v1.phv00099923.v1,phs000287.v7.p1,phv00099923.v1.p1,pht001451.v1.p1,BASE2,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,fasting_lipids_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,fasting_lipids_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00253225,HCHS_SOL,fasting_lipids_1,Fasting time (hrs.),FASTTIME,phs000810.v1.pht004715.v1.phv00253225.v1,phs000810.v2.p2,phv00253225.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00082639,MESA,fasting_lipids_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083303,MESA,fasting_lipids_1,HOW LONG AGO LAST DRINK OR EAT? (HRS),lastdrk1,phs000209.v13.pht001111.v4.phv00083303.v1,phs000209.v13.p3,phv00083303.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,fasting_lipids_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084980,MESA,fasting_lipids_1,HOW LONG AGO LAST DRINK OR EAT? (HRS),lastdrk1,phs000209.v13.pht001116.v10.phv00084980.v2,phs000209.v13.p3,phv00084980.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,fasting_lipids_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087524,MESA,fasting_lipids_1,HOW LONG AGO LAST DRINK OR EAT? (hrs),lastdrkf,phs000209.v13.pht001121.v3.phv00087524.v1,phs000209.v13.p3,phv00087524.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,lipid_lowering_medication_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204802,ARIC,lipid_lowering_medication_1,"Cholesterol lowering medication in past 2 weeks: using 2004 Med. code, visit 1 [Cohort. Visit 1]",CHOLMDCODE01,phs000280.v4.pht004063.v2.phv00204802.v1,phs000280.v8.p2,phv00204802.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,lipid_lowering_medication_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100594,CHS,lipid_lowering_medication_1,Any lipid-lowering medication,LIPID06,phs000287.v6.pht001452.v1.phv00100594.v1,phs000287.v7.p1,phv00100594.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,lipid_lowering_medication_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226349,HCHS_SOL,lipid_lowering_medication_1,Lipid lowering drugs/Antihyperlipidemics (LLD),MED_LLD,phs000810.v1.pht004715.v1.phv00226349.v1,phs000810.v2.p2,phv00226349.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00082639,MESA,lipid_lowering_medication_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083162,MESA,lipid_lowering_medication_1,ANY LIPID-LOWERING MEDICATION,lipid1c,phs000209.v13.pht001111.v4.phv00083162.v1,phs000209.v13.p3,phv00083162.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,lipid_lowering_medication_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085407,MESA,lipid_lowering_medication_1,ANY LIPID-LOWERING MEDICATION,lipid1c,phs000209.v13.pht001116.v10.phv00085407.v2,phs000209.v13.p3,phv00085407.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,lipid_lowering_medication_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087104,MESA,lipid_lowering_medication_1,ANY LIPID-LOWERING MEDICATION,lipidfc,phs000209.v13.pht001121.v3.phv00087104.v1,phs000209.v13.p3,phv00087104.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,triglycerides_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204738,ARIC,triglycerides_1,Total triglycerides In SI units [Cohort. Visit 1],TRGSIU01,phs000280.v4.pht004063.v2.phv00204738.v1,phs000280.v8.p2,phv00204738.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,triglycerides_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113701,CARDIA,triglycerides_1,TRIGLYCERIDES (MG/DL),AL1NTRIG,phs000285.v3.pht001588.v2.phv00113701.v2,phs000285.v3.p2,phv00113701.v2.p2,pht001588.v2.p2,A4LIP,CARDIA Cohort
phv00100425,CHS,triglycerides_1,TRIGLYCERIDE (mg/dl),TRIG44,phs000287.v6.pht001452.v1.phv00100425.v1,phs000287.v7.p1,phv00100425.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,triglycerides_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,triglycerides_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00253240,HCHS_SOL,triglycerides_1,Triglycerides (mg/dL) (LABA67),LABA67,phs000810.v1.pht004715.v1.phv00253240.v1,phs000810.v2.p2,phv00253240.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00125933,JHS,triglycerides_1,Trr: triglyceride - mg/dL [Visit 1],TRR,phs000286.v5.pht001945.v1.phv00125933.v1,phs000286.v7.p2,phv00125933.v2.p2,pht001945.v2.p2,cena,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,triglycerides_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082950,MESA,triglycerides_1,TRIGLYCERIDES (mg/dl),trig1,phs000209.v13.pht001111.v4.phv00082950.v1,phs000209.v13.p3,phv00082950.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,triglycerides_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084968,MESA,triglycerides_1,TRIGLYCERIDES (mg/dl),trig1,phs000209.v13.pht001116.v10.phv00084968.v2,phs000209.v13.p3,phv00084968.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,triglycerides_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087101,MESA,triglycerides_1,TRIGLYCERIDES (mg/dl),trigf,phs000209.v13.pht001121.v3.phv00087101.v1,phs000209.v13.p3,phv00087101.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,hdl_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204761,ARIC,hdl_1,HDL cholesterol (recalibrated lipid) [Cohort. Visit 1],HDL01,phs000280.v4.pht004063.v2.phv00204761.v1,phs000280.v8.p2,phv00204761.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,hdl_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00113702,CARDIA,hdl_1,TOTAL HDL CHOLESTEROL (MG/DL),AL1HDL,phs000285.v3.pht001588.v2.phv00113702.v2,phs000285.v3.p2,phv00113702.v2.p2,pht001588.v2.p2,A4LIP,CARDIA Cohort
phv00100426,CHS,hdl_1,HDL (mg/dl),HDL44,phs000287.v6.pht001452.v1.phv00100426.v1,phs000287.v7.p1,phv00100426.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,hdl_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,hdl_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00253239,HCHS_SOL,hdl_1,HDL-cholesterol (mg/dL) (LABA68),LABA68,phs000810.v1.pht004715.v1.phv00253239.v1,phs000810.v2.p2,phv00253239.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00125930,JHS,hdl_1,Hdlc: HDL cholesterol - mg/dL [Visit 1],HDLC,phs000286.v5.pht001945.v1.phv00125930.v1,phs000286.v7.p2,phv00125930.v2.p2,pht001945.v2.p2,cena,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,hdl_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082952,MESA,hdl_1,HDL CHOLESTEROL (mg/dl),hdl1,phs000209.v13.pht001111.v4.phv00082952.v1,phs000209.v13.p3,phv00082952.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,hdl_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084972,MESA,hdl_1,HDL CHOLESTEROL (mg/dl),hdl1,phs000209.v13.pht001116.v10.phv00084972.v2,phs000209.v13.p3,phv00084972.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,hdl_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087099,MESA,hdl_1,HDL CHOLESTEROL (mg/dl),hdlf,phs000209.v13.pht001121.v3.phv00087099.v1,phs000209.v13.p3,phv00087099.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,vte_followup_start_age_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,vte_followup_start_age_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00204712,ARIC,vte_case_status_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,vte_case_status_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00273565,CHS,vte_case_status_1,Lite: VT case (through dec01),vt,phs000287.v6.pht005981.v1.phv00273565.v1,phs000287.v7.p1,phv00273565.v1.p1,pht005981.v1.p1,CHS_VTE_data,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00273566,CHS,vte_case_status_1,Days from baseline to VT or censoring (through dec01),ttoevent,phs000287.v6.pht005981.v1.phv00273566.v1,phs000287.v7.p1,phv00273566.v1.p1,pht005981.v1.p1,CHS_VTE_data,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00273567,CHS,vte_case_status_1,LITE : Self-report of DVT or PE at baseline,vtpehx01,phs000287.v6.pht005981.v1.phv00273567.v1,phs000287.v7.p1,phv00273567.v1.p1,pht005981.v1.p1,CHS_VTE_data,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00204712,ARIC,vte_prior_history_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,vte_prior_history_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00273567,CHS,vte_prior_history_1,LITE : Self-report of DVT or PE at baseline,vtpehx01,phs000287.v6.pht005981.v1.phv00273567.v1,phs000287.v7.p1,phv00273567.v1.p1,pht005981.v1.p1,CHS_VTE_data,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100290,CHS,carotid_stenosis_1,COHORT,PERSTAT,phs000287.v6.pht001452.v1.phv00100290.v1,phs000287.v7.p1,phv00100290.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,carotid_stenosis_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101302,CHS,carotid_stenosis_1,"YEAR 5 PERCENT STENOSIS, RT SIDE",PSTEN141,phs000287.v6.pht001473.v1.phv00101302.v1,phs000287.v7.p1,phv00101302.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101303,CHS,carotid_stenosis_1,"YEAR 5 PERCENT STENOSIS, LFT SIDE",PSTEN241,phs000287.v6.pht001473.v1.phv00101303.v1,phs000287.v7.p1,phv00101303.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101313,CHS,carotid_stenosis_1,"BL REREAD PERCENT STENOSIS, RT SIDE",PSTEN155,phs000287.v6.pht001473.v1.phv00101313.v1,phs000287.v7.p1,phv00101313.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101314,CHS,carotid_stenosis_1,"BL REREAD PERCENT STENOSIS, LFT SIDE",PSTEN255,phs000287.v6.pht001473.v1.phv00101314.v1,phs000287.v7.p1,phv00101314.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00021700,FHS,carotid_stenosis_1,PERCENT STENOSIS ON THE RIGHT,R_STENO,phs000007.v29.pht000083.v6.phv00021700.v5,phs000007.v33.p14,phv00021700.v8.p14,pht000083.v9.p14,carotid1_6s,Framingham Cohort
phv00021702,FHS,carotid_stenosis_1,PERCENT STENOSIS ON THE LEFT,L_STENO,phs000007.v29.pht000083.v6.phv00021702.v5,phs000007.v33.p14,phv00021702.v8.p14,pht000083.v9.p14,carotid1_6s,Framingham Cohort
phv00177940,FHS,carotid_stenosis_1,Age at Exam 6,age6,phs000007.v29.pht003099.v4.phv00177940.v4,phs000007.v33.p14,phv00177940.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00082639,MESA,carotid_stenosis_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,carotid_stenosis_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084798,MESA,carotid_stenosis_1,RIGHT STENOSIS,rsten1,phs000209.v13.pht001116.v10.phv00084798.v2,phs000209.v13.p3,phv00084798.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084803,MESA,carotid_stenosis_1,LEFT STENOSIS,lsten1,phs000209.v13.pht001116.v10.phv00084803.v2,phs000209.v13.p3,phv00084803.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,carotid_stenosis_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,cimt_2,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v3.pht004063.v1.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211053,ARIC,cimt_2,"Maximum near wall width, left common carotid: optimal angle [Ultrasound Derived Data. UBMD4. Visit 1]",LOPAMX23,phs000280.v3.pht004207.v1.phv00211053.v1,phs000280.v8.p2,phv00211053.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211054,ARIC,cimt_2,"Maximum near wall width, left common carotid: anterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",LANAMX23,phs000280.v3.pht004207.v1.phv00211054.v1,phs000280.v8.p2,phv00211054.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211055,ARIC,cimt_2,"Maximum near wall width, left common carotid: posterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",LPOAMX23,phs000280.v3.pht004207.v1.phv00211055.v1,phs000280.v8.p2,phv00211055.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211059,ARIC,cimt_2,"Maximum near wall width, right common carotid: optimal angle [Ultrasound Derived Data. UBMD4. Visit 1]",ROPAMX23,phs000280.v3.pht004207.v1.phv00211059.v1,phs000280.v8.p2,phv00211059.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211060,ARIC,cimt_2,"Maximum near wall width, right common carotid: anterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",RANAMX23,phs000280.v3.pht004207.v1.phv00211060.v1,phs000280.v8.p2,phv00211060.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211061,ARIC,cimt_2,"Maximum near wall width, right common carotid: posterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",RPOAMX23,phs000280.v3.pht004207.v1.phv00211061.v1,phs000280.v8.p2,phv00211061.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211081,ARIC,cimt_2,"Maximum far wall width, left common carotid: optimal angle [Ultrasound Derived Data. UBMD4. Visit 1]",LOPAMX45,phs000280.v3.pht004207.v1.phv00211081.v1,phs000280.v8.p2,phv00211081.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211082,ARIC,cimt_2,"Maximum far wall width, left common carotid: anterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",LANAMX45,phs000280.v3.pht004207.v1.phv00211082.v1,phs000280.v8.p2,phv00211082.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211083,ARIC,cimt_2,"Maximum far wall width, left common carotid: posterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",LPOAMX45,phs000280.v3.pht004207.v1.phv00211083.v1,phs000280.v8.p2,phv00211083.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211087,ARIC,cimt_2,"Maximum far wall width, right common carotid: optimal angle [Ultrasound Derived Data. UBMD4. Visit 1]",ROPAMX45,phs000280.v3.pht004207.v1.phv00211087.v1,phs000280.v8.p2,phv00211087.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211088,ARIC,cimt_2,"Maximum far wall width, right common carotid: anterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",RANAMX45,phs000280.v3.pht004207.v1.phv00211088.v1,phs000280.v8.p2,phv00211088.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211089,ARIC,cimt_2,"Maximum far wall width, right common carotid: posterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",RPOAMX45,phs000280.v3.pht004207.v1.phv00211089.v1,phs000280.v8.p2,phv00211089.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100290,CHS,cimt_2,COHORT,PERSTAT,phs000287.v6.pht001452.v1.phv00100290.v1,phs000287.v7.p1,phv00100290.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,cimt_2,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101238,CHS,cimt_2,"BL REREAD NEAR WALL MAX, R. COMMON",NMAX155,phs000287.v6.pht001473.v1.phv00101238.v1,phs000287.v7.p1,phv00101238.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101239,CHS,cimt_2,"BL REREAD FAR WALL MAX, R. COMMON",FMAX155,phs000287.v6.pht001473.v1.phv00101239.v1,phs000287.v7.p1,phv00101239.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101250,CHS,cimt_2,"BL REREAD NEAR WALL MAX, L. COMMON",NMAX555,phs000287.v6.pht001473.v1.phv00101250.v1,phs000287.v7.p1,phv00101250.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101251,CHS,cimt_2,"BL REREAD FAR WALL MAX, L. COMMON",FMAX555,phs000287.v6.pht001473.v1.phv00101251.v1,phs000287.v7.p1,phv00101251.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101264,CHS,cimt_2,"YEAR 5 NEAR WALL MAX, R. COMMON",NMAX141,phs000287.v6.pht001473.v1.phv00101264.v1,phs000287.v7.p1,phv00101264.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101265,CHS,cimt_2,"YEAR 5 FAR WALL MAX, R. COMMON",FMAX141,phs000287.v6.pht001473.v1.phv00101265.v1,phs000287.v7.p1,phv00101265.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101276,CHS,cimt_2,"YEAR 5 NEAR WALL MAX, L. COMMON",NMAX541,phs000287.v6.pht001473.v1.phv00101276.v1,phs000287.v7.p1,phv00101276.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101277,CHS,cimt_2,"YEAR 5 FAR WALL MAX, L. COMMON",FMAX541,phs000287.v6.pht001473.v1.phv00101277.v1,phs000287.v7.p1,phv00101277.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00021728,FHS,cimt_2,MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN DIASTOLE (MM),CCD_MEMX,phs000007.v29.pht000083.v6.phv00021728.v5,phs000007.v33.p14,phv00021728.v8.p14,pht000083.v9.p14,carotid1_6s,Framingham Cohort
phv00177940,FHS,cimt_2,Age at Exam 6,age6,phs000007.v29.pht003099.v4.phv00177940.v4,phs000007.v33.p14,phv00177940.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177930,FHS,cac_volume_1,Age at Exam 1,age1,phs000007.v29.pht003099.v4.phv00177930.v4,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00257671,FHS,cac_volume_1,Coronary artery calcium volume,CAC_V,phs000007.v29.pht005161.v1.phv00257671.v1,phs000007.v33.p14,phv00257671.v4.p14,pht005161.v4.p14,t_ctthrcac_2011_m_0682s,Framingham Cohort
phv00257672,FHS,cac_volume_1,CT scan date,scan_date,phs000007.v29.pht005161.v1.phv00257672.v1,phs000007.v33.p14,phv00257672.v4.p14,pht005161.v4.p14,t_ctthrcac_2011_m_0682s,Framingham Cohort
phv00204712,ARIC,carotid_plaque_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v3.pht004063.v1.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204791,ARIC,carotid_plaque_1,Plaque (with or without shadowing) in any carotid site [Cohort. Visit 1],PLAQUE01,phs000280.v3.pht004063.v1.phv00204791.v1,phs000280.v8.p2,phv00204791.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100290,CHS,carotid_plaque_1,COHORT,PERSTAT,phs000287.v6.pht001452.v1.phv00100290.v1,phs000287.v7.p1,phv00100290.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,carotid_plaque_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101306,CHS,carotid_plaque_1,"YEAR 5 LESION MORPHOLOGY, RT SIDE",LMRPH141,phs000287.v6.pht001473.v1.phv00101306.v1,phs000287.v7.p1,phv00101306.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101307,CHS,carotid_plaque_1,"YEAR 5 LESION MORPHOLOGY, LFT SIDE",LMRPH241,phs000287.v6.pht001473.v1.phv00101307.v1,phs000287.v7.p1,phv00101307.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101317,CHS,carotid_plaque_1,"BL REREAD LESION MORPHOLOGY, RT SIDE",LMRPH155,phs000287.v6.pht001473.v1.phv00101317.v1,phs000287.v7.p1,phv00101317.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00101318,CHS,carotid_plaque_1,"BL REREAD LESION MORPHOLOGY, LFT SIDE",LMRPH255,phs000287.v6.pht001473.v1.phv00101318.v1,phs000287.v7.p1,phv00101318.v1.p1,pht001473.v1.p1,ULTRAYR5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00082639,MESA,carotid_plaque_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,carotid_plaque_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084797,MESA,carotid_plaque_1,RIGHT MORPHOLOGY,rmorph1,phs000209.v13.pht001116.v10.phv00084797.v2,phs000209.v13.p3,phv00084797.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084802,MESA,carotid_plaque_1,LEFT MORPHOLOGY,lmorph1,phs000209.v13.pht001116.v10.phv00084802.v2,phs000209.v13.p3,phv00084802.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,carotid_plaque_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00100691,CHS,cac_score_1,Coronary Artery Calcification by electron beam CYT scan,CACSCORE,phs000287.v6.pht001459.v1.phv00100691.v1,phs000287.v7.p1,phv00100691.v1.p1,pht001459.v1.p1,CHS_CAC,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00102583,CHS,cac_score_1,AGE AT YEAR 11,AGEY11,phs000287.v6.pht001475.v1.phv00102583.v1,phs000287.v7.p1,phv00102583.v1.p1,pht001475.v1.p1,YR11,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00126002,JHS,cac_score_1,24. Agatston Score All Coronary (does not include others),CSTA24,phs000286.v5.pht001948.v1.phv00126002.v1,phs000286.v7.p2,phv00126002.v2.p2,pht001948.v3.p2,csta,Jackson Heart Study (JHS) Cohort
phv00204712,ARIC,cimt_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v3.pht004063.v1.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211095,ARIC,cimt_1,"Average far wall width, left common carotid: optimal angle [Ultrasound Derived Data. UBMD4. Visit 1]",LOPAAV45,phs000280.v3.pht004207.v1.phv00211095.v1,phs000280.v8.p2,phv00211095.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211096,ARIC,cimt_1,"Average far wall width, left common carotid: anterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",LANAAV45,phs000280.v3.pht004207.v1.phv00211096.v1,phs000280.v8.p2,phv00211096.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211097,ARIC,cimt_1,"Average far wall width, left common carotid: posterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",LPOAAV45,phs000280.v3.pht004207.v1.phv00211097.v1,phs000280.v8.p2,phv00211097.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211101,ARIC,cimt_1,"Average far wall width, right common carotid: optimal angle [Ultrasound Derived Data. UBMD4. Visit 1]",ROPAAV45,phs000280.v3.pht004207.v1.phv00211101.v1,phs000280.v8.p2,phv00211101.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211102,ARIC,cimt_1,"Average far wall width, right common carotid: anterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",RANAAV45,phs000280.v3.pht004207.v1.phv00211102.v1,phs000280.v8.p2,phv00211102.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00211103,ARIC,cimt_1,"Average far wall width, right common carotid: posterior angle [Ultrasound Derived Data. UBMD4. Visit 1]",RPOAAV45,phs000280.v3.pht004207.v1.phv00211103.v1,phs000280.v8.p2,phv00211103.v2.p2,pht004207.v3.p2,UBMD4,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00100487,CHS,cimt_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100864,CHS,cimt_1,Mean of the mean far wall intima media t (var=CCA_FWME),CCA_FWME,phs000287.v6.pht001468.v1.phv00100864.v1,phs000287.v7.p1,phv00100864.v1.p1,pht001468.v1.p1,IMT_POLACK,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00076366,FHS,cimt_1,Mean of the mean common carotid IMT far wall of both sides,cca_fw_mean_imt,phs000007.v29.pht000907.v5.phv00076366.v4,phs000007.v33.p14,phv00076366.v7.p14,pht000907.v8.p14,imtcarotid1_6s,Framingham Cohort
phv00177940,FHS,cimt_1,Age at Exam 6,age6,phs000007.v29.pht003099.v4.phv00177940.v4,phs000007.v33.p14,phv00177940.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00204871,ARIC,mcv_entvol_rbc_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207282,ARIC,mcv_entvol_rbc_1,Mean corpuscular volume (MCV) (to nearest whole unit). Q13 [Hematology Form. HMTB. Visit 2],HMTB13,phs000280.v4.pht004108.v2.phv00207282.v1,phs000280.v8.p2,phv00207282.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207293,ARIC,mcv_entvol_rbc_1,MCV. Q6 [Hematology Lab. HMTCV301. Visit 3],HMTC6,phs000280.v4.pht004109.v2.phv00207293.v1,phs000280.v8.p2,phv00207293.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207305,ARIC,mcv_entvol_rbc_1,MCV. Q6 [Hematology Lab. HMTCV401. Visit 4],HMTC6,phs000280.v4.pht004110.v2.phv00207305.v1,phs000280.v8.p2,phv00207305.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294959,ARIC,mcv_entvol_rbc_1,"Mean cell volume, Mcv [Complete Blood Count, CBC, Visit 5]",CBC8,phs000280.v4.pht006422.v1.phv00294959.v1,phs000280.v8.p2,phv00294959.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,mcv_entvol_rbc_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112687,CARDIA,mcv_entvol_rbc_1,"RED CELL COUNT (X 1,000,000)",A05RBC,phs000285.v3.pht001563.v2.phv00112687.v2,phs000285.v3.p2,phv00112687.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112689,CARDIA,mcv_entvol_rbc_1,HEMATOCRIT (%),A05HCT,phs000285.v3.pht001563.v2.phv00112689.v2,phs000285.v3.p2,phv00112689.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,mcv_entvol_rbc_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226304,HCHS_SOL,mcv_entvol_rbc_1,Mean Corpuscular Volume (fl) (LABA5),LABA5,phs000810.v1.pht004715.v1.phv00226304.v1,phs000810.v2.p2,phv00226304.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127625,JHS,mcv_entvol_rbc_1,Mcv FL [Visit 1],MCV,phs000286.v5.pht001959.v1.phv00127625.v1,phs000286.v7.p2,phv00127625.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,mcv_entvol_rbc_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218990,MESA,mcv_entvol_rbc_1,RED BLOOD CELL (RBC) (x10E6/uL),rbc5,phs000209.v13.pht004319.v1.phv00218990.v1,phs000209.v13.p3,phv00218990.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218992,MESA,mcv_entvol_rbc_1,HEMATOCRIT (%),hct5,phs000209.v13.pht004319.v1.phv00218992.v1,phs000209.v13.p3,phv00218992.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,hematocrit_vfr_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204871,ARIC,hematocrit_vfr_bld_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207255,ARIC,hematocrit_vfr_bld_1,Hematocrit % (MAV). Q1 [Hematology Form. HMTA. Visit 1],HMTA01,phs000280.v4.pht004107.v2.phv00207255.v1,phs000280.v8.p2,phv00207255.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207270,ARIC,hematocrit_vfr_bld_1,Hematocrit % (MAV). Q1 [Hematology Form. HMTB. Visit 2],HMTB01,phs000280.v4.pht004108.v2.phv00207270.v1,phs000280.v8.p2,phv00207270.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207289,ARIC,hematocrit_vfr_bld_1,Hematocrit. Q5 [Hematology Lab. HMTCV301. Visit 3],HMTC5,phs000280.v4.pht004109.v2.phv00207289.v1,phs000280.v8.p2,phv00207289.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207301,ARIC,hematocrit_vfr_bld_1,Hematocrit. Q5 [Hematology Lab. HMTCV401. Visit 4],HMTC5,phs000280.v4.pht004110.v2.phv00207301.v1,phs000280.v8.p2,phv00207301.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294957,ARIC,hematocrit_vfr_bld_1,"Hematocrit, Hct [Complete Blood Count, CBC, Visit 5]",CBC6,phs000280.v4.pht006422.v1.phv00294957.v1,phs000280.v8.p2,phv00294957.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,hematocrit_vfr_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112689,CARDIA,hematocrit_vfr_bld_1,HEMATOCRIT (%),A05HCT,phs000285.v3.pht001563.v2.phv00112689.v2,phs000285.v3.p2,phv00112689.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00100413,CHS,hematocrit_vfr_bld_1,HEMATOCRIT (%),HEMATO23,phs000287.v6.pht001452.v1.phv00100413.v1,phs000287.v7.p1,phv00100413.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,hematocrit_vfr_bld_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,hematocrit_vfr_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226303,HCHS_SOL,hematocrit_vfr_bld_1,% Hematocrit (LABA4),LABA4,phs000810.v1.pht004715.v1.phv00226303.v1,phs000810.v2.p2,phv00226303.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127614,JHS,hematocrit_vfr_bld_1,Hematocrit % [Visit 1],HEMATOCRIT,phs000286.v5.pht001959.v1.phv00127614.v1,phs000286.v7.p2,phv00127614.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,hematocrit_vfr_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218992,MESA,hematocrit_vfr_bld_1,HEMATOCRIT (%),hct5,phs000209.v13.pht004319.v1.phv00218992.v1,phs000209.v13.p3,phv00218992.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00077362,WHI,hematocrit_vfr_bld_1,CBC Visit year,CBCVY,phs000200.v11.pht000986.v6.phv00077362.v6,phs000200.v12.p3,phv00077362.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077363,WHI,hematocrit_vfr_bld_1,CBC Days since randomization/enrollment,CBCDAYS,phs000200.v11.pht000986.v6.phv00077363.v6,phs000200.v12.p3,phv00077363.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077365,WHI,hematocrit_vfr_bld_1,Hematocrit (%),HEMATOCR,phs000200.v11.pht000986.v6.phv00077365.v6,phs000200.v12.p3,phv00077365.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00078436,WHI,hematocrit_vfr_bld_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,hematocrit_vfr_bld_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00204712,ARIC,basophil_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207257,ARIC,basophil_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTA. Visit 1],HMTA03,phs000280.v4.pht004107.v2.phv00207257.v1,phs000280.v8.p2,phv00207257.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207264,ARIC,basophil_ncnc_bld_1,Basophils % Q10 [Hematology Form. HMTA. Visit 1],HMTA10,phs000280.v4.pht004107.v2.phv00207264.v1,phs000280.v8.p2,phv00207264.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207272,ARIC,basophil_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTB. Visit 2],HMTB03,phs000280.v4.pht004108.v2.phv00207272.v1,phs000280.v8.p2,phv00207272.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207279,ARIC,basophil_ncnc_bld_1,Basophils %. Q10 [Hematology Form. HMTB. Visit 2],HMTB10,phs000280.v4.pht004108.v2.phv00207279.v1,phs000280.v8.p2,phv00207279.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,basophil_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112686,CARDIA,basophil_ncnc_bld_1,WHITE CELL COUNT (X 1000),A05WBC,phs000285.v3.pht001563.v2.phv00112686.v2,phs000285.v3.p2,phv00112686.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112696,CARDIA,basophil_ncnc_bld_1,BASOPHILS (%),A05BASO,phs000285.v3.pht001563.v2.phv00112696.v2,phs000285.v3.p2,phv00112696.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,basophil_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226283,HCHS_SOL,basophil_ncnc_bld_1,White Blood Count (x10e9) (LABA1),LABA1,phs000810.v1.pht004715.v1.phv00226283.v1,phs000810.v2.p2,phv00226283.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226288,HCHS_SOL,basophil_ncnc_bld_1,% Basophils (LABA14),LABA14,phs000810.v1.pht004715.v1.phv00226288.v1,phs000810.v2.p2,phv00226288.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127620,JHS,basophil_ncnc_bld_1,Baso: diff measure % [Visit 1],BASO,phs000286.v5.pht001959.v1.phv00127620.v1,phs000286.v7.p2,phv00127620.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00127631,JHS,basophil_ncnc_bld_1,White blood cells TH/CMM [Visit 1],WBC,phs000286.v5.pht001959.v1.phv00127631.v1,phs000286.v7.p2,phv00127631.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,basophil_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00219002,MESA,basophil_ncnc_bld_1,BASOPHIL (ABSOLUTE) (x10E3/uL),basosa5,phs000209.v13.pht004319.v1.phv00219002.v1,phs000209.v13.p3,phv00219002.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,monocyte_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207257,ARIC,monocyte_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTA. Visit 1],HMTA03,phs000280.v4.pht004107.v2.phv00207257.v1,phs000280.v8.p2,phv00207257.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207262,ARIC,monocyte_ncnc_bld_1,Monocytes % Q8 [Hematology Form. HMTA. Visit 1],HMTA08,phs000280.v4.pht004107.v2.phv00207262.v1,phs000280.v8.p2,phv00207262.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207272,ARIC,monocyte_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTB. Visit 2],HMTB03,phs000280.v4.pht004108.v2.phv00207272.v1,phs000280.v8.p2,phv00207272.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207277,ARIC,monocyte_ncnc_bld_1,Monocytes %. Q8 [Hematology Form. HMTB. Visit 2],HMTB08,phs000280.v4.pht004108.v2.phv00207277.v1,phs000280.v8.p2,phv00207277.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294954,ARIC,monocyte_ncnc_bld_1,"White blood cell count, Wbc [Complete Blood Count, CBC, Visit 5]",CBC3,phs000280.v4.pht006422.v1.phv00294954.v1,phs000280.v8.p2,phv00294954.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294965,ARIC,monocyte_ncnc_bld_1,"Monocyte percentage, Mo [Complete Blood Count, CBC, Visit 5]",CBC14,phs000280.v4.pht006422.v1.phv00294965.v1,phs000280.v8.p2,phv00294965.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,monocyte_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112686,CARDIA,monocyte_ncnc_bld_1,WHITE CELL COUNT (X 1000),A05WBC,phs000285.v3.pht001563.v2.phv00112686.v2,phs000285.v3.p2,phv00112686.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112692,CARDIA,monocyte_ncnc_bld_1,MONOCYTES (%),A05MONO,phs000285.v3.pht001563.v2.phv00112692.v2,phs000285.v3.p2,phv00112692.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,monocyte_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226283,HCHS_SOL,monocyte_ncnc_bld_1,White Blood Count (x10e9) (LABA1),LABA1,phs000810.v1.pht004715.v1.phv00226283.v1,phs000810.v2.p2,phv00226283.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226286,HCHS_SOL,monocyte_ncnc_bld_1,% Monocytes (LABA12),LABA12,phs000810.v1.pht004715.v1.phv00226286.v1,phs000810.v2.p2,phv00226286.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127626,JHS,monocyte_ncnc_bld_1,Monos: diff % [Visit 1],MONOS,phs000286.v5.pht001959.v1.phv00127626.v1,phs000286.v7.p2,phv00127626.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00127631,JHS,monocyte_ncnc_bld_1,White blood cells TH/CMM [Visit 1],WBC,phs000286.v5.pht001959.v1.phv00127631.v1,phs000286.v7.p2,phv00127631.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,monocyte_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00219000,MESA,monocyte_ncnc_bld_1,MONOCYTES(ABSOLUTE) (x10E3/uL),monosa5,phs000209.v13.pht004319.v1.phv00219000.v1,phs000209.v13.p3,phv00219000.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,eosinophil_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207257,ARIC,eosinophil_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTA. Visit 1],HMTA03,phs000280.v4.pht004107.v2.phv00207257.v1,phs000280.v8.p2,phv00207257.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207263,ARIC,eosinophil_ncnc_bld_1,Eosinophils % Q9 [Hematology Form. HMTA. Visit 1],HMTA09,phs000280.v4.pht004107.v2.phv00207263.v1,phs000280.v8.p2,phv00207263.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207272,ARIC,eosinophil_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTB. Visit 2],HMTB03,phs000280.v4.pht004108.v2.phv00207272.v1,phs000280.v8.p2,phv00207272.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207278,ARIC,eosinophil_ncnc_bld_1,Eosinophils %. Q9 [Hematology Form. HMTB. Visit 2],HMTB09,phs000280.v4.pht004108.v2.phv00207278.v1,phs000280.v8.p2,phv00207278.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,eosinophil_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112686,CARDIA,eosinophil_ncnc_bld_1,WHITE CELL COUNT (X 1000),A05WBC,phs000285.v3.pht001563.v2.phv00112686.v2,phs000285.v3.p2,phv00112686.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112693,CARDIA,eosinophil_ncnc_bld_1,EOSINPHILS (%),A05EOSIN,phs000285.v3.pht001563.v2.phv00112693.v2,phs000285.v3.p2,phv00112693.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,eosinophil_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226283,HCHS_SOL,eosinophil_ncnc_bld_1,White Blood Count (x10e9) (LABA1),LABA1,phs000810.v1.pht004715.v1.phv00226283.v1,phs000810.v2.p2,phv00226283.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226287,HCHS_SOL,eosinophil_ncnc_bld_1,% Eosiniphils (LABA13),LABA13,phs000810.v1.pht004715.v1.phv00226287.v1,phs000810.v2.p2,phv00226287.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127621,JHS,eosinophil_ncnc_bld_1,Eosin: diff measure % [Visit 1],EOSIN,phs000286.v5.pht001959.v1.phv00127621.v1,phs000286.v7.p2,phv00127621.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00127631,JHS,eosinophil_ncnc_bld_1,White blood cells TH/CMM [Visit 1],WBC,phs000286.v5.pht001959.v1.phv00127631.v1,phs000286.v7.p2,phv00127631.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,eosinophil_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00219001,MESA,eosinophil_ncnc_bld_1,EOSINOPHILS (ABSOLUTE) (x10E3/uL),eosa5,phs000209.v13.pht004319.v1.phv00219001.v1,phs000209.v13.p3,phv00219001.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204871,ARIC,rbc_ncnc_bld_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207287,ARIC,rbc_ncnc_bld_1,Red blood count. Q3 [Hematology Lab. HMTCV301. Visit 3],HMTC3,phs000280.v4.pht004109.v2.phv00207287.v1,phs000280.v8.p2,phv00207287.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207299,ARIC,rbc_ncnc_bld_1,Red blood count. Q3 [Hematology Lab. HMTCV401. Visit 4],HMTC3,phs000280.v4.pht004110.v2.phv00207299.v1,phs000280.v8.p2,phv00207299.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294955,ARIC,rbc_ncnc_bld_1,"Red blood cell count, Rbc [Complete Blood Count, CBC, Visit 5]",CBC4,phs000280.v4.pht006422.v1.phv00294955.v1,phs000280.v8.p2,phv00294955.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,rbc_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112687,CARDIA,rbc_ncnc_bld_1,"RED CELL COUNT (X 1,000,000)",A05RBC,phs000285.v3.pht001563.v2.phv00112687.v2,phs000285.v3.p2,phv00112687.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,rbc_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226294,HCHS_SOL,rbc_ncnc_bld_1,Red Blood Count (x10e12) (LABA2),LABA2,phs000810.v1.pht004715.v1.phv00226294.v1,phs000810.v2.p2,phv00226294.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127629,JHS,rbc_ncnc_bld_1,Red cell count M/CMM [Visit 1],RED_CELL_COUNT,phs000286.v5.pht001959.v1.phv00127629.v1,phs000286.v7.p2,phv00127629.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,rbc_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218990,MESA,rbc_ncnc_bld_1,RED BLOOD CELL (RBC) (x10E6/uL),rbc5,phs000209.v13.pht004319.v1.phv00218990.v1,phs000209.v13.p3,phv00218990.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,platelet_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204871,ARIC,platelet_ncnc_bld_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207258,ARIC,platelet_ncnc_bld_1,Platelet count x1000/mm3 (MAV). Q4 [Hematology Form. HMTA. Visit 1],HMTA04,phs000280.v4.pht004107.v2.phv00207258.v1,phs000280.v8.p2,phv00207258.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207273,ARIC,platelet_ncnc_bld_1,Platelet count x1000/mm3 (MAV). Q4 [Hematology Form. HMTB. Visit 2],HMTB04,phs000280.v4.pht004108.v2.phv00207273.v1,phs000280.v8.p2,phv00207273.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207294,ARIC,platelet_ncnc_bld_1,Platelet count Q10 [Hematology Lab. HMTCV301. Visit 3],HMTC10,phs000280.v4.pht004109.v2.phv00207294.v1,phs000280.v8.p2,phv00207294.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207306,ARIC,platelet_ncnc_bld_1,Platelet count. Q10 [Hematology Lab. HMTCV401. Visit 4],HMTC10,phs000280.v4.pht004110.v2.phv00207306.v1,phs000280.v8.p2,phv00207306.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294958,ARIC,platelet_ncnc_bld_1,"Platelet count, Plt [Complete Blood Count, CBC, Visit 5]",CBC7,phs000280.v4.pht006422.v1.phv00294958.v1,phs000280.v8.p2,phv00294958.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,platelet_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112690,CARDIA,platelet_ncnc_bld_1,PLATELET COUNT,A05PLATL,phs000285.v3.pht001563.v2.phv00112690.v2,phs000285.v3.p2,phv00112690.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00100414,CHS,platelet_ncnc_bld_1,PLATELET COUNT (/cc.mm),PLATE23,phs000287.v6.pht001452.v1.phv00100414.v1,phs000287.v7.p1,phv00100414.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,platelet_ncnc_bld_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,platelet_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226310,HCHS_SOL,platelet_ncnc_bld_1,Platelet Count (x10e9) (LABA9),LABA9,phs000810.v1.pht004715.v1.phv00226310.v1,phs000810.v2.p2,phv00226310.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127616,JHS,platelet_ncnc_bld_1,Platelet TH/CMM [Visit 1],PLATELET,phs000286.v5.pht001959.v1.phv00127616.v1,phs000286.v7.p2,phv00127616.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,platelet_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218991,MESA,platelet_ncnc_bld_1,PLATELETS (x10E3/uL),plt5,phs000209.v13.pht004319.v1.phv00218991.v1,phs000209.v13.p3,phv00218991.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00077362,WHI,platelet_ncnc_bld_1,CBC Visit year,CBCVY,phs000200.v11.pht000986.v6.phv00077362.v6,phs000200.v12.p3,phv00077362.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077363,WHI,platelet_ncnc_bld_1,CBC Days since randomization/enrollment,CBCDAYS,phs000200.v11.pht000986.v6.phv00077363.v6,phs000200.v12.p3,phv00077363.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077367,WHI,platelet_ncnc_bld_1,Platelet count (Kcell/microliter),PLATELET,phs000200.v11.pht000986.v6.phv00077367.v6,phs000200.v12.p3,phv00077367.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00078436,WHI,platelet_ncnc_bld_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,platelet_ncnc_bld_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00204712,ARIC,wbc_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204871,ARIC,wbc_ncnc_bld_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207257,ARIC,wbc_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTA. Visit 1],HMTA03,phs000280.v4.pht004107.v2.phv00207257.v1,phs000280.v8.p2,phv00207257.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207272,ARIC,wbc_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTB. Visit 2],HMTB03,phs000280.v4.pht004108.v2.phv00207272.v1,phs000280.v8.p2,phv00207272.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207286,ARIC,wbc_ncnc_bld_1,White blood count. Q2 [Hematology Lab. HMTCV301. Visit 3],HMTC2,phs000280.v4.pht004109.v2.phv00207286.v1,phs000280.v8.p2,phv00207286.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207298,ARIC,wbc_ncnc_bld_1,White blood count. Q2 [Hematology Lab. HMTCV401. Visit 4],HMTC2,phs000280.v4.pht004110.v2.phv00207298.v1,phs000280.v8.p2,phv00207298.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294954,ARIC,wbc_ncnc_bld_1,"White blood cell count, Wbc [Complete Blood Count, CBC, Visit 5]",CBC3,phs000280.v4.pht006422.v1.phv00294954.v1,phs000280.v8.p2,phv00294954.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,wbc_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112686,CARDIA,wbc_ncnc_bld_1,WHITE CELL COUNT (X 1000),A05WBC,phs000285.v3.pht001563.v2.phv00112686.v2,phs000285.v3.p2,phv00112686.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00100411,CHS,wbc_ncnc_bld_1,"WHITE BLOOD COUNT (x1, 000/cubic mm)",WBLD23,phs000287.v6.pht001452.v1.phv00100411.v1,phs000287.v7.p1,phv00100411.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,wbc_ncnc_bld_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,wbc_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226283,HCHS_SOL,wbc_ncnc_bld_1,White Blood Count (x10e9) (LABA1),LABA1,phs000810.v1.pht004715.v1.phv00226283.v1,phs000810.v2.p2,phv00226283.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127631,JHS,wbc_ncnc_bld_1,White blood cells TH/CMM [Visit 1],WBC,phs000286.v5.pht001959.v1.phv00127631.v1,phs000286.v7.p2,phv00127631.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,wbc_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218997,MESA,wbc_ncnc_bld_1,WHITE BLOOD CELL COUNT (x10E3/uL),wbc5,phs000209.v13.pht004319.v1.phv00218997.v1,phs000209.v13.p3,phv00218997.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00077362,WHI,wbc_ncnc_bld_1,CBC Visit year,CBCVY,phs000200.v11.pht000986.v6.phv00077362.v6,phs000200.v12.p3,phv00077362.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077363,WHI,wbc_ncnc_bld_1,CBC Days since randomization/enrollment,CBCDAYS,phs000200.v11.pht000986.v6.phv00077363.v6,phs000200.v12.p3,phv00077363.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077368,WHI,wbc_ncnc_bld_1,White blood cell (Kcell/microliter),WBC,phs000200.v11.pht000986.v6.phv00077368.v6,phs000200.v12.p3,phv00077368.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00078436,WHI,wbc_ncnc_bld_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,wbc_ncnc_bld_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00204712,ARIC,hemoglobin_mcnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204871,ARIC,hemoglobin_mcnc_bld_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207256,ARIC,hemoglobin_mcnc_bld_1,Hemoglobin g/dL (MAV). Q2 [Hematology Form. HMTA. Visit 1],HMTA02,phs000280.v4.pht004107.v2.phv00207256.v1,phs000280.v8.p2,phv00207256.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207271,ARIC,hemoglobin_mcnc_bld_1,Hemoglobin g/dL (MAV). Q2 [Hematology Form. HMTB. Visit 2],HMTB02,phs000280.v4.pht004108.v2.phv00207271.v1,phs000280.v8.p2,phv00207271.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207288,ARIC,hemoglobin_mcnc_bld_1,Hemoglobin. Q4 [Hematology Lab. HMTCV301. Visit 3],HMTC4,phs000280.v4.pht004109.v2.phv00207288.v1,phs000280.v8.p2,phv00207288.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207300,ARIC,hemoglobin_mcnc_bld_1,Hemoglobin. Q4 [Hematology Lab. HMTCV401. Visit 4],HMTC4,phs000280.v4.pht004110.v2.phv00207300.v1,phs000280.v8.p2,phv00207300.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294956,ARIC,hemoglobin_mcnc_bld_1,"Hemoglobin, Hgb [Complete Blood Count, CBC, Visit 5]",CBC5,phs000280.v4.pht006422.v1.phv00294956.v1,phs000280.v8.p2,phv00294956.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,hemoglobin_mcnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112688,CARDIA,hemoglobin_mcnc_bld_1,HEMOGLOBIN (G/DL),A05HGB,phs000285.v3.pht001563.v2.phv00112688.v2,phs000285.v3.p2,phv00112688.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00100412,CHS,hemoglobin_mcnc_bld_1,HEMOGLOBIN (g/dl),HEMOGL23,phs000287.v6.pht001452.v1.phv00100412.v1,phs000287.v7.p1,phv00100412.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,hemoglobin_mcnc_bld_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,hemoglobin_mcnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226302,HCHS_SOL,hemoglobin_mcnc_bld_1,Hemoglobin (g/dL) (LABA3),LABA3,phs000810.v1.pht004715.v1.phv00226302.v1,phs000810.v2.p2,phv00226302.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127615,JHS,hemoglobin_mcnc_bld_1,Hemoglobin G/DL [Visit 1],HEMOGLOBIN,phs000286.v5.pht001959.v1.phv00127615.v1,phs000286.v7.p2,phv00127615.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,hemoglobin_mcnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218993,MESA,hemoglobin_mcnc_bld_1,HEMOGLOBIN (g/dL),hgb5,phs000209.v13.pht004319.v1.phv00218993.v1,phs000209.v13.p3,phv00218993.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00077362,WHI,hemoglobin_mcnc_bld_1,CBC Visit year,CBCVY,phs000200.v11.pht000986.v6.phv00077362.v6,phs000200.v12.p3,phv00077362.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077363,WHI,hemoglobin_mcnc_bld_1,CBC Days since randomization/enrollment,CBCDAYS,phs000200.v11.pht000986.v6.phv00077363.v6,phs000200.v12.p3,phv00077363.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00077366,WHI,hemoglobin_mcnc_bld_1,Hemoglobin (gm/dl),HEMOGLBN,phs000200.v11.pht000986.v6.phv00077366.v6,phs000200.v12.p3,phv00077366.v6.p3,pht000986.v6.p3,cbc_rel1,Women's Health Initiative
phv00078436,WHI,hemoglobin_mcnc_bld_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,hemoglobin_mcnc_bld_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00204712,ARIC,mchc_mcnc_rbc_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204871,ARIC,mchc_mcnc_rbc_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207255,ARIC,mchc_mcnc_rbc_1,Hematocrit % (MAV). Q1 [Hematology Form. HMTA. Visit 1],HMTA01,phs000280.v4.pht004107.v2.phv00207255.v1,phs000280.v8.p2,phv00207255.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207256,ARIC,mchc_mcnc_rbc_1,Hemoglobin g/dL (MAV). Q2 [Hematology Form. HMTA. Visit 1],HMTA02,phs000280.v4.pht004107.v2.phv00207256.v1,phs000280.v8.p2,phv00207256.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207270,ARIC,mchc_mcnc_rbc_1,Hematocrit % (MAV). Q1 [Hematology Form. HMTB. Visit 2],HMTB01,phs000280.v4.pht004108.v2.phv00207270.v1,phs000280.v8.p2,phv00207270.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207271,ARIC,mchc_mcnc_rbc_1,Hemoglobin g/dL (MAV). Q2 [Hematology Form. HMTB. Visit 2],HMTB02,phs000280.v4.pht004108.v2.phv00207271.v1,phs000280.v8.p2,phv00207271.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207288,ARIC,mchc_mcnc_rbc_1,Hemoglobin. Q4 [Hematology Lab. HMTCV301. Visit 3],HMTC4,phs000280.v4.pht004109.v2.phv00207288.v1,phs000280.v8.p2,phv00207288.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207289,ARIC,mchc_mcnc_rbc_1,Hematocrit. Q5 [Hematology Lab. HMTCV301. Visit 3],HMTC5,phs000280.v4.pht004109.v2.phv00207289.v1,phs000280.v8.p2,phv00207289.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207300,ARIC,mchc_mcnc_rbc_1,Hemoglobin. Q4 [Hematology Lab. HMTCV401. Visit 4],HMTC4,phs000280.v4.pht004110.v2.phv00207300.v1,phs000280.v8.p2,phv00207300.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207301,ARIC,mchc_mcnc_rbc_1,Hematocrit. Q5 [Hematology Lab. HMTCV401. Visit 4],HMTC5,phs000280.v4.pht004110.v2.phv00207301.v1,phs000280.v8.p2,phv00207301.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294956,ARIC,mchc_mcnc_rbc_1,"Hemoglobin, Hgb [Complete Blood Count, CBC, Visit 5]",CBC5,phs000280.v4.pht006422.v1.phv00294956.v1,phs000280.v8.p2,phv00294956.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294957,ARIC,mchc_mcnc_rbc_1,"Hematocrit, Hct [Complete Blood Count, CBC, Visit 5]",CBC6,phs000280.v4.pht006422.v1.phv00294957.v1,phs000280.v8.p2,phv00294957.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,mchc_mcnc_rbc_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112688,CARDIA,mchc_mcnc_rbc_1,HEMOGLOBIN (G/DL),A05HGB,phs000285.v3.pht001563.v2.phv00112688.v2,phs000285.v3.p2,phv00112688.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112689,CARDIA,mchc_mcnc_rbc_1,HEMATOCRIT (%),A05HCT,phs000285.v3.pht001563.v2.phv00112689.v2,phs000285.v3.p2,phv00112689.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00100412,CHS,mchc_mcnc_rbc_1,HEMOGLOBIN (g/dl),HEMOGL23,phs000287.v6.pht001452.v1.phv00100412.v1,phs000287.v7.p1,phv00100412.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100413,CHS,mchc_mcnc_rbc_1,HEMATOCRIT (%),HEMATO23,phs000287.v6.pht001452.v1.phv00100413.v1,phs000287.v7.p1,phv00100413.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,mchc_mcnc_rbc_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,mchc_mcnc_rbc_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226306,HCHS_SOL,mchc_mcnc_rbc_1,Mean Corpuscular Hemoglobin Concentration (g/dL)(LABA7),LABA7,phs000810.v1.pht004715.v1.phv00226306.v1,phs000810.v2.p2,phv00226306.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127624,JHS,mchc_mcnc_rbc_1,Mchc % [Visit 1],MCHC,phs000286.v5.pht001959.v1.phv00127624.v1,phs000286.v7.p2,phv00127624.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,mchc_mcnc_rbc_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218992,MESA,mchc_mcnc_rbc_1,HEMATOCRIT (%),hct5,phs000209.v13.pht004319.v1.phv00218992.v1,phs000209.v13.p3,phv00218992.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218993,MESA,mchc_mcnc_rbc_1,HEMOGLOBIN (g/dL),hgb5,phs000209.v13.pht004319.v1.phv00218993.v1,phs000209.v13.p3,phv00218993.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204871,ARIC,mch_entmass_rbc_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207290,ARIC,mch_entmass_rbc_1,MCH. Q7 [Hematology Lab. HMTCV301. Visit 3],HMTC7,phs000280.v4.pht004109.v2.phv00207290.v1,phs000280.v8.p2,phv00207290.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207302,ARIC,mch_entmass_rbc_1,MCH. Q7 [Hematology Lab. HMTCV401. Visit 4],HMTC7,phs000280.v4.pht004110.v2.phv00207302.v1,phs000280.v8.p2,phv00207302.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294960,ARIC,mch_entmass_rbc_1,"Mean corpuscular hemoglobin, Mch [Complete Blood Count, CBC, Visit 5]",CBC9,phs000280.v4.pht006422.v1.phv00294960.v1,phs000280.v8.p2,phv00294960.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,mch_entmass_rbc_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112687,CARDIA,mch_entmass_rbc_1,"RED CELL COUNT (X 1,000,000)",A05RBC,phs000285.v3.pht001563.v2.phv00112687.v2,phs000285.v3.p2,phv00112687.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112688,CARDIA,mch_entmass_rbc_1,HEMOGLOBIN (G/DL),A05HGB,phs000285.v3.pht001563.v2.phv00112688.v2,phs000285.v3.p2,phv00112688.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,mch_entmass_rbc_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226305,HCHS_SOL,mch_entmass_rbc_1,Mean Corpuscular Hemoglobin (pg) (LABA6),LABA6,phs000810.v1.pht004715.v1.phv00226305.v1,phs000810.v2.p2,phv00226305.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127623,JHS,mch_entmass_rbc_1,MCH PG [Visit 1],MCH,phs000286.v5.pht001959.v1.phv00127623.v1,phs000286.v7.p2,phv00127623.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,mch_entmass_rbc_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218990,MESA,mch_entmass_rbc_1,RED BLOOD CELL (RBC) (x10E6/uL),rbc5,phs000209.v13.pht004319.v1.phv00218990.v1,phs000209.v13.p3,phv00218990.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218993,MESA,mch_entmass_rbc_1,HEMOGLOBIN (g/dL),hgb5,phs000209.v13.pht004319.v1.phv00218993.v1,phs000209.v13.p3,phv00218993.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,neutrophil_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207257,ARIC,neutrophil_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTA. Visit 1],HMTA03,phs000280.v4.pht004107.v2.phv00207257.v1,phs000280.v8.p2,phv00207257.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207259,ARIC,neutrophil_ncnc_bld_1,Neutrophils % Q5 [Hematology Form. HMTA. Visit 1],HMTA05,phs000280.v4.pht004107.v2.phv00207259.v1,phs000280.v8.p2,phv00207259.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207260,ARIC,neutrophil_ncnc_bld_1,Neutrophil Bands % Q6 [Hematology Form. HMTA. Visit 1],HMTA06,phs000280.v4.pht004107.v2.phv00207260.v1,phs000280.v8.p2,phv00207260.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207272,ARIC,neutrophil_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTB. Visit 2],HMTB03,phs000280.v4.pht004108.v2.phv00207272.v1,phs000280.v8.p2,phv00207272.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207274,ARIC,neutrophil_ncnc_bld_1,Neutrophils % Q5. Q5 [Hematology Form. HMTB. Visit 2],HMTB05,phs000280.v4.pht004108.v2.phv00207274.v1,phs000280.v8.p2,phv00207274.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207275,ARIC,neutrophil_ncnc_bld_1,Neutrophil Bands %.Q6 [Hematology Form. HMTB. Visit 2],HMTB06,phs000280.v4.pht004108.v2.phv00207275.v1,phs000280.v8.p2,phv00207275.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,neutrophil_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112686,CARDIA,neutrophil_ncnc_bld_1,WHITE CELL COUNT (X 1000),A05WBC,phs000285.v3.pht001563.v2.phv00112686.v2,phs000285.v3.p2,phv00112686.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112694,CARDIA,neutrophil_ncnc_bld_1,NEUTROPHILS (%),A05NEUTR,phs000285.v3.pht001563.v2.phv00112694.v2,phs000285.v3.p2,phv00112694.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112695,CARDIA,neutrophil_ncnc_bld_1,GRANULOCYTES (%),A05GRAN,phs000285.v3.pht001563.v2.phv00112695.v2,phs000285.v3.p2,phv00112695.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112697,CARDIA,neutrophil_ncnc_bld_1,BANDS (%),A05BANDS,phs000285.v3.pht001563.v2.phv00112697.v2,phs000285.v3.p2,phv00112697.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112698,CARDIA,neutrophil_ncnc_bld_1,SEGS (%),A05SEGS,phs000285.v3.pht001563.v2.phv00112698.v2,phs000285.v3.p2,phv00112698.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,neutrophil_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226283,HCHS_SOL,neutrophil_ncnc_bld_1,White Blood Count (x10e9) (LABA1),LABA1,phs000810.v1.pht004715.v1.phv00226283.v1,phs000810.v2.p2,phv00226283.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226284,HCHS_SOL,neutrophil_ncnc_bld_1,% Neutrophils (LABA10),LABA10,phs000810.v1.pht004715.v1.phv00226284.v1,phs000810.v2.p2,phv00226284.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127630,JHS,neutrophil_ncnc_bld_1,Segs: diff measure % [Visit 1],SEGS,phs000286.v5.pht001959.v1.phv00127630.v1,phs000286.v7.p2,phv00127630.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00127631,JHS,neutrophil_ncnc_bld_1,White blood cells TH/CMM [Visit 1],WBC,phs000286.v5.pht001959.v1.phv00127631.v1,phs000286.v7.p2,phv00127631.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00127632,JHS,neutrophil_ncnc_bld_1,Bands: diff measure % [Visit 1],BANDS,phs000286.v5.pht001959.v1.phv00127632.v1,phs000286.v7.p2,phv00127632.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,neutrophil_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218999,MESA,neutrophil_ncnc_bld_1,NEUTROPHILS (ABSOLUTE) (x10E3/uL),polysa5,phs000209.v13.pht004319.v1.phv00218999.v1,phs000209.v13.p3,phv00218999.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,lymphocyte_ncnc_bld_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207257,ARIC,lymphocyte_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTA. Visit 1],HMTA03,phs000280.v4.pht004107.v2.phv00207257.v1,phs000280.v8.p2,phv00207257.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207261,ARIC,lymphocyte_ncnc_bld_1,Lymphocytes % Q7 [Hematology Form. HMTA. Visit 1],HMTA07,phs000280.v4.pht004107.v2.phv00207261.v1,phs000280.v8.p2,phv00207261.v2.p2,pht004107.v3.p2,HMTA,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207272,ARIC,lymphocyte_ncnc_bld_1,White blood count x1000/mm3 (MAV). Q3 [Hematology Form. HMTB. Visit 2],HMTB03,phs000280.v4.pht004108.v2.phv00207272.v1,phs000280.v8.p2,phv00207272.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207276,ARIC,lymphocyte_ncnc_bld_1,Lymphocytes %. Q7 [Hematology Form. HMTB. Visit 2],HMTB07,phs000280.v4.pht004108.v2.phv00207276.v1,phs000280.v8.p2,phv00207276.v2.p2,pht004108.v3.p2,HMTB,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294954,ARIC,lymphocyte_ncnc_bld_1,"White blood cell count, Wbc [Complete Blood Count, CBC, Visit 5]",CBC3,phs000280.v4.pht006422.v1.phv00294954.v1,phs000280.v8.p2,phv00294954.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294964,ARIC,lymphocyte_ncnc_bld_1,"Lymphocyte percentage, Ly [Complete Blood Count, CBC, Visit 5]",CBC13,phs000280.v4.pht006422.v1.phv00294964.v1,phs000280.v8.p2,phv00294964.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112439,CARDIA,lymphocyte_ncnc_bld_1,AGE VERIFY,A01AGE2,phs000285.v3.pht001559.v2.phv00112439.v2,phs000285.v3.p2,phv00112439.v2.p2,pht001559.v2.p2,A4F01,CARDIA Cohort
phv00112686,CARDIA,lymphocyte_ncnc_bld_1,WHITE CELL COUNT (X 1000),A05WBC,phs000285.v3.pht001563.v2.phv00112686.v2,phs000285.v3.p2,phv00112686.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00112691,CARDIA,lymphocyte_ncnc_bld_1,LYMPHOCYTE COUNT,A05LYMPH,phs000285.v3.pht001563.v2.phv00112691.v2,phs000285.v3.p2,phv00112691.v2.p2,pht001563.v2.p2,A4F05,CARDIA Cohort
phv00226251,HCHS_SOL,lymphocyte_ncnc_bld_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226283,HCHS_SOL,lymphocyte_ncnc_bld_1,White Blood Count (x10e9) (LABA1),LABA1,phs000810.v1.pht004715.v1.phv00226283.v1,phs000810.v2.p2,phv00226283.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226285,HCHS_SOL,lymphocyte_ncnc_bld_1,% Lymphocytes (LABA11),LABA11,phs000810.v1.pht004715.v1.phv00226285.v1,phs000810.v2.p2,phv00226285.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127622,JHS,lymphocyte_ncnc_bld_1,Lymphs: diff measure % [Visit 1],LYMPHS,phs000286.v5.pht001959.v1.phv00127622.v1,phs000286.v7.p2,phv00127622.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00127631,JHS,lymphocyte_ncnc_bld_1,White blood cells TH/CMM [Visit 1],WBC,phs000286.v5.pht001959.v1.phv00127631.v1,phs000286.v7.p2,phv00127631.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00176011,MESA,lymphocyte_ncnc_bld_1,AGE AT EXAM 5,age5c,phs000209.v13.pht003091.v3.phv00176011.v1,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00218998,MESA,lymphocyte_ncnc_bld_1,LYMPHOCYTES (ABSOLUTE) (x10E3/uL),lymphsa5,phs000209.v13.pht004319.v1.phv00218998.v1,phs000209.v13.p3,phv00218998.v1.p3,pht004319.v1.p3,MESA_AncilMesaEpigenomicCBC,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204871,ARIC,rdw_ratio_rbc_1,Age at visit 3 [Cohort. Visit 3],V3AGE31,phs000280.v4.pht004064.v2.phv00204871.v1,phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207292,ARIC,rdw_ratio_rbc_1,RBC distribution width. Q9 [Hematology Lab. HMTCV301. Visit 3],HMTC9,phs000280.v4.pht004109.v2.phv00207292.v1,phs000280.v8.p2,phv00207292.v2.p2,pht004109.v3.p2,HMTCV301,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00207304,ARIC,rdw_ratio_rbc_1,RBC distribution width. Q9 [Hematology Lab. HMTCV401. Visit 4],HMTC9,phs000280.v4.pht004110.v2.phv00207304.v1,phs000280.v8.p2,phv00207304.v2.p2,pht004110.v3.p2,HMTCV401,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00294962,ARIC,rdw_ratio_rbc_1,"Red cell distribution width, Rdw [Complete Blood Count, CBC, Visit 5]",CBC11,phs000280.v4.pht006422.v1.phv00294962.v1,phs000280.v8.p2,phv00294962.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00226251,HCHS_SOL,rdw_ratio_rbc_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226308,HCHS_SOL,rdw_ratio_rbc_1,% Red Cell Distribution Width (LABA8),LABA8,phs000810.v1.pht004715.v1.phv00226308.v1,phs000810.v2.p2,phv00226308.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00127628,JHS,rdw_ratio_rbc_1,RDW [Visit 1],RDW,phs000286.v5.pht001959.v1.phv00127628.v1,phs000286.v7.p2,phv00127628.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00294963,ARIC,pmv_entvol_bld_1,"Mean platelet volume, Mpv [Complete Blood Count, CBC, Visit 5]",CBC12,phs000280.v4.pht006422.v1.phv00294963.v1,phs000280.v8.p2,phv00294963.v2.p2,pht006422.v2.p2,CBC,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00127627,JHS,pmv_entvol_bld_1,Mpv FL [Visit 1],MPV,phs000286.v5.pht001959.v1.phv00127627.v1,phs000286.v7.p2,phv00127627.v2.p2,pht001959.v2.p2,loca,Jackson Heart Study (JHS) Cohort
phv00098770,CHS,lppla2_act_1,Baseline LP-PLA2 Activity (nmols/min/mL),LPPLA2AC,phs000287.v6.pht001449.v1.phv00098770.v1,phs000287.v7.p1,phv00098770.v1.p1,pht001449.v1.p1,ADDITIONAL_BIOMARKERS,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,lppla2_act_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00177928,FHS,lppla2_act_1,Framingham Heart Study cohort identifier,idtype,phs000007.v29.pht003099.v4.phv00177928.v4,phs000007.v33.p14,phv00177928.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177930,FHS,lppla2_act_1,Age at Exam 1,age1,phs000007.v29.pht003099.v4.phv00177930.v4,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177934,FHS,lppla2_act_1,Age at Exam 3,age3,phs000007.v29.pht003099.v4.phv00177934.v4,phs000007.v33.p14,phv00177934.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177942,FHS,lppla2_act_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00084442,MESA,lppla2_act_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00165052,MESA,lppla2_act_1,LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2: ACTIVITY,cam1a,phs000209.v13.pht002512.v1.phv00165052.v1,phs000209.v13.p3,phv00165052.v1.p3,pht002512.v1.p3,MESA_AncilMesaLpPLA2,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,mmp9_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085027,MESA,mmp9_1,MATRIX METALLOPROTEINASE 9 (ng/mL),mmp91,phs000209.v13.pht001116.v10.phv00085027.v2,phs000209.v13.p3,phv00085027.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00177928,FHS,isoprostane_8_epi_pgf2a_1,Framingham Heart Study cohort identifier,idtype,phs000007.v29.pht003099.v4.phv00177928.v4,phs000007.v33.p14,phv00177928.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177930,FHS,isoprostane_8_epi_pgf2a_1,Age at Exam 1,age1,phs000007.v29.pht003099.v4.phv00177930.v4,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177934,FHS,isoprostane_8_epi_pgf2a_1,Age at Exam 3,age3,phs000007.v29.pht003099.v4.phv00177934.v4,phs000007.v33.p14,phv00177934.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177942,FHS,isoprostane_8_epi_pgf2a_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00098769,CHS,lppla2_mass_1,Baseline LP-PLA2 Mass (ng/ml),LPPLA2,phs000287.v6.pht001449.v1.phv00098769.v1,phs000287.v7.p1,phv00098769.v1.p1,pht001449.v1.p1,ADDITIONAL_BIOMARKERS,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,lppla2_mass_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00177928,FHS,lppla2_mass_1,Framingham Heart Study cohort identifier,idtype,phs000007.v29.pht003099.v4.phv00177928.v4,phs000007.v33.p14,phv00177928.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177930,FHS,lppla2_mass_1,Age at Exam 1,age1,phs000007.v29.pht003099.v4.phv00177930.v4,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177934,FHS,lppla2_mass_1,Age at Exam 3,age3,phs000007.v29.pht003099.v4.phv00177934.v4,phs000007.v33.p14,phv00177934.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177942,FHS,lppla2_mass_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00084442,MESA,lppla2_mass_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00165050,MESA,lppla2_mass_1,LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2: MASS,plac1a,phs000209.v13.pht002512.v1.phv00165050.v1,phs000209.v13.p3,phv00165050.v1.p3,pht002512.v1.p3,MESA_AncilMesaLpPLA2,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00120748,CARDIA,il6_1,CALCULATED AGE AT EXAM 6,EX6_AGE,phs000285.v3.pht001851.v2.phv00120748.v2,phs000285.v3.p2,phv00120748.v2.p2,pht001851.v2.p2,F1REF,CARDIA Cohort
phv00121064,CARDIA,il6_1,IL6 PG/ML,FL6IL6,phs000285.v3.pht001862.v2.phv00121064.v2,phs000285.v3.p2,phv00121064.v2.p2,pht001862.v2.p2,F2IGFIL,CARDIA Cohort
phv00121065,CARDIA,il6_1,IL6 COMMENTS,FL6IL6CM,phs000285.v3.pht001862.v2.phv00121065.v2,phs000285.v3.p2,phv00121065.v2.p2,pht001862.v2.p2,F2IGFIL,CARDIA Cohort
phv00100487,CHS,il6_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100500,CHS,il6_1,IL-6 at baseline (pg/ml),IL6BL,phs000287.v6.pht001452.v1.phv00100500.v1,phs000287.v7.p1,phv00100500.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00084442,MESA,il6_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085009,MESA,il6_1,INTERLEUKIN-6 (IL-6) (pg/mL),il61,phs000209.v13.pht001116.v10.phv00085009.v2,phs000209.v13.p3,phv00085009.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085010,MESA,il6_1,EXCEPTIONAL MISSING IL61,il61M,phs000209.v13.pht001116.v10.phv00085010.v2,phs000209.v13.p3,phv00085010.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,tnfa_r1_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085029,MESA,tnfa_r1_1,TUMOR NECROSIS FACTOR-A SOLUBLE RECEPTORS (pg/ml),tnfri1,phs000209.v13.pht001116.v10.phv00085029.v3,phs000209.v13.p3,phv00085029.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00177942,FHS,mpo_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177928,FHS,tnfr2_1,Framingham Heart Study cohort identifier,idtype,phs000007.v29.pht003099.v4.phv00177928.v4,phs000007.v33.p14,phv00177928.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177930,FHS,tnfr2_1,Age at Exam 1,age1,phs000007.v29.pht003099.v4.phv00177930.v4,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177934,FHS,tnfr2_1,Age at Exam 3,age3,phs000007.v29.pht003099.v4.phv00177934.v4,phs000007.v33.p14,phv00177934.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00177942,FHS,tnfr2_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00082639,MESA,eselectin_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082969,MESA,eselectin_1,E-SELECTIN (ng/mL),eselect1,phs000209.v13.pht001111.v4.phv00082969.v1,phs000209.v13.p3,phv00082969.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00082970,MESA,eselectin_1,E-SELECTIN MISSING VALUE,eselect1m,phs000209.v13.pht001111.v4.phv00082970.v1,phs000209.v13.p3,phv00082970.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,eselectin_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085022,MESA,eselectin_1,E-SELECTIN (ng/mL),eselect1,phs000209.v13.pht001116.v10.phv00085022.v2,phs000209.v13.p3,phv00085022.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00177942,FHS,tnfa_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00085773,MESA,tnfa_1,AGE AT EXAM 2,age2c,phs000209.v13.pht001118.v8.phv00085773.v3,phs000209.v13.p3,phv00085773.v3.p3,pht001118.v8.p3,MESA_Exam2Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00086259,MESA,tnfa_1,AGE AT EXAM3,age3c,phs000209.v13.pht001119.v8.phv00086259.v4,phs000209.v13.p3,phv00086259.v4.p3,pht001119.v8.p3,MESA_Exam3Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00160529,MESA,tnfa_1,EXAM,exam3,phs000209.v13.pht002198.v2.phv00160529.v1,phs000209.v13.p3,phv00160529.v1.p3,pht002198.v2.p3,MESA_AncilMesaAbdBodyComposition,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00160540,MESA,tnfa_1,TNFa (pg/mL),tnfa3,phs000209.v13.pht002198.v2.phv00160540.v1,phs000209.v13.p3,phv00160540.v1.p3,pht002198.v2.p3,MESA_AncilMesaAbdBodyComposition,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00160541,MESA,tnfa_1,TNFa (MISSING VALUE REASON),tnfa3m,phs000209.v13.pht002198.v2.phv00160541.v1,phs000209.v13.p3,phv00160541.v1.p3,pht002198.v2.p3,MESA_AncilMesaAbdBodyComposition,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00177942,FHS,il18_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00084442,MESA,il10_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00142666,MESA,il10_1,INTERLEUKIN-10,il10a1,phs000209.v13.pht002099.v2.phv00142666.v2,phs000209.v13.p3,phv00142666.v2.p3,pht002099.v2.p3,MESA_AncilMesaIL10,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00142667,MESA,il10_1,MISSING INTERLEUKIN-10 VALUE: REASON,il10a1m,phs000209.v13.pht002099.v2.phv00142667.v2,phs000209.v13.p3,phv00142667.v2.p3,pht002099.v2.p3,MESA_AncilMesaIL10,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00116390,CARDIA,icam1_1,CALCULATED AGE AT EXAM 3,EX3_AGE,phs000285.v3.pht001697.v2.phv00116390.v2,phs000285.v3.p2,phv00116390.v2.p2,pht001697.v2.p2,C1REF,CARDIA Cohort
phv00116396,CARDIA,icam1_1,SICAM1,sICAM1,phs000285.v3.pht001699.v2.phv00116396.v2,phs000285.v3.p2,phv00116396.v2.p2,pht001699.v2.p2,CARE_ICAM,CARDIA Cohort
phv00098764,CHS,icam1_1,BASELINE ICAM-1 -sample,ICAM1,phs000287.v6.pht001449.v1.phv00098764.v1,phs000287.v7.p1,phv00098764.v1.p1,pht001449.v1.p1,ADDITIONAL_BIOMARKERS,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,icam1_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00296696,ARIC,crp_1,High sensitive C reactive protein [Central Lab Data],LIP33,phs000280.v4.pht006444.v1.phv00296696.v1,phs000280.v8.p2,phv00296696.v2.p2,pht006444.v2.p2,LIP,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00120748,CARDIA,crp_1,CALCULATED AGE AT EXAM 6,EX6_AGE,phs000285.v3.pht001851.v2.phv00120748.v2,phs000285.v3.p2,phv00120748.v2.p2,pht001851.v2.p2,F1REF,CARDIA Cohort
phv00120759,CARDIA,crp_1,RERUN CRP (uG/ml - BNII METHOD),FL6CRPBN,phs000285.v3.pht001853.v2.phv00120759.v2,phs000285.v3.p2,phv00120759.v2.p2,pht001853.v2.p2,F2CRP,CARDIA Cohort
phv00100487,CHS,crp_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100499,CHS,crp_1,"C-reactive protein, adjusted original va",CRPBLADJ,phs000287.v6.pht001452.v1.phv00100499.v1,phs000287.v7.p1,phv00100499.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,crp_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00258066,HCHS_SOL,crp_1,High-sensitivity C-Reactive Protein (mg/L) (LABA91),LABA91,phs000810.v1.pht004715.v1.phv00258066.v1,phs000810.v2.p2,phv00258066.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00125940,JHS,crp_1,Character results for Hscrp [Visit 1],Hscrp_cresult,phs000286.v5.pht001945.v1.phv00125940.v1,phs000286.v7.p2,phv00125940.v2.p2,pht001945.v2.p2,cena,Jackson Heart Study (JHS) Cohort
phv00125941,JHS,crp_1,Hscrp: high sensitivity C-reactive protein in mg/dL [Visit 1],HSCRP,phs000286.v5.pht001945.v1.phv00125941.v1,phs000286.v7.p2,phv00125941.v2.p2,pht001945.v2.p2,cena,Jackson Heart Study (JHS) Cohort
phv00177942,FHS,cd40_1,Age at Exam 7,age7,phs000007.v29.pht003099.v4.phv00177942.v4,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,Framingham Cohort
phv00084442,MESA,cd40_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085021,MESA,cd40_1,CD40 LIGAND (pg/mL),cd40l1,phs000209.v13.pht001116.v10.phv00085021.v2,phs000209.v13.p3,phv00085021.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00204712,ARIC,antihypertensive_meds_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00204754,ARIC,antihypertensive_meds_1,Blood pressure lowering medications in the past 2 weeks [Cohort. Visit 1],HYPTMD01,phs000280.v4.pht004063.v2.phv00204754.v1,phs000280.v8.p2,phv00204754.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00113012,CARDIA,antihypertensive_meds_1,EVER TAKEN MEDS FOR HIGH BLOOD PRESSURE,A08BPMED,phs000285.v3.pht001569.v2.phv00113012.v2,phs000285.v3.p2,phv00113012.v2.p2,pht001569.v2.p2,A4F08,CARDIA Cohort
phv00113154,CARDIA,antihypertensive_meds_1,MEDIC'N FOLL'UP PAGE NAME (MED TYPE),A09MDTYP,phs000285.v3.pht001571.v2.phv00113154.v2,phs000285.v3.p2,phv00113154.v2.p2,pht001571.v2.p2,A4F09MED,CARDIA Cohort
phv00113155,CARDIA,antihypertensive_meds_1,TAKING MED NOW?,A09MDNOW,phs000285.v3.pht001571.v2.phv00113155.v2,phs000285.v3.p2,phv00113155.v2.p2,pht001571.v2.p2,A4F09MED,CARDIA Cohort
phv00115119,CARDIA,antihypertensive_meds_1,AGE AT EXAM 1 (VERIFIED AT EXAM 2),EXAMAGE,phs000285.v3.pht001645.v2.phv00115119.v2,phs000285.v3.p2,phv00115119.v2.p2,pht001645.v2.p2,B2REF,CARDIA Cohort
phv00100487,CHS,antihypertensive_meds_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100595,CHS,antihypertensive_meds_1,Any hypertension medication,HTNMED06,phs000287.v6.pht001452.v1.phv00100595.v1,phs000287.v7.p1,phv00100595.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00226251,HCHS_SOL,antihypertensive_meds_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226324,HCHS_SOL,antihypertensive_meds_1,Antihypertensives,MED_ANTIHYPERT,phs000810.v1.pht004715.v1.phv00226324.v1,phs000810.v2.p2,phv00226324.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00082639,MESA,antihypertensive_meds_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083163,MESA,antihypertensive_meds_1,HYPERTENSION MEDICATION,htnmed1c,phs000209.v13.pht001111.v4.phv00083163.v1,phs000209.v13.p3,phv00083163.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,antihypertensive_meds_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085324,MESA,antihypertensive_meds_1,HYPERTENSION MEDICATION,htnmed1c,phs000209.v13.pht001116.v10.phv00085324.v2,phs000209.v13.p3,phv00085324.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,antihypertensive_meds_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087093,MESA,antihypertensive_meds_1,ANY HYPERTENSION MEDICATION,htnmedfc,phs000209.v13.pht001121.v3.phv00087093.v1,phs000209.v13.p3,phv00087093.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,antihypertensive_meds_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,antihypertensive_meds_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079850,WHI,antihypertensive_meds_1,Visit Type,F80VTYP,phs000200.v11.pht001019.v6.phv00079850.v6,phs000200.v12.p3,phv00079850.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079852,WHI,antihypertensive_meds_1,F80 Days since randomization/enrollment,F80DAYS,phs000200.v11.pht001019.v6.phv00079852.v6,phs000200.v12.p3,phv00079852.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00169603,WHI,antihypertensive_meds_1,Visit Type,F44VTYP,phs000200.v11.pht002754.v4.phv00169603.v4,phs000200.v12.p3,phv00169603.v4.p3,pht002754.v4.p3,f44_rel1,Women's Health Initiative
phv00169605,WHI,antihypertensive_meds_1,F44 Days since randomization/enrollment,F44DAYS,phs000200.v11.pht002754.v4.phv00169605.v4,phs000200.v12.p3,phv00169605.v4.p3,pht002754.v4.p3,f44_rel1,Women's Health Initiative
phv00169608,WHI,antihypertensive_meds_1,F44 Adult duration of medication use (days),ADULTDY,phs000200.v11.pht002754.v4.phv00169608.v4,phs000200.v12.p3,phv00169608.v4.p3,pht002754.v4.p3,f44_rel1,Women's Health Initiative
phv00169611,WHI,antihypertensive_meds_1,F44 Medication Therapeutic Class Code,TCCODE,phs000200.v11.pht002754.v4.phv00169611.v4,phs000200.v12.p3,phv00169611.v4.p3,pht002754.v4.p3,f44_rel1,Women's Health Initiative
phv00204712,ARIC,bp_diastolic_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210284,ARIC,bp_diastolic_1,[Second blood pressure measurement]. 2nd systolic. Q15 [Siting Blood Pressure. SBPA. Visit 1],SBPA15,phs000280.v4.pht004192.v2.phv00210284.v1,phs000280.v8.p2,phv00210284.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210285,ARIC,bp_diastolic_1,[Second blood pressure measurement]. 2nd diastolic. Q16 [Siting Blood Pressure. SBPA. Visit 1],SBPA16,phs000280.v4.pht004192.v2.phv00210285.v1,phs000280.v8.p2,phv00210285.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210286,ARIC,bp_diastolic_1,[Second blood pressure measurement]. 2nd zero reading. Q17 [Siting Blood Pressure. SBPA. Visit 1],SBPA17,phs000280.v4.pht004192.v2.phv00210286.v1,phs000280.v8.p2,phv00210286.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210287,ARIC,bp_diastolic_1,[Third blood pressure measurement]. 3rd systolic. Q18 [Siting Blood Pressure. SBPA. Visit 1],SBPA18,phs000280.v4.pht004192.v2.phv00210287.v1,phs000280.v8.p2,phv00210287.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210288,ARIC,bp_diastolic_1,[Third blood pressure measurement]. 3rd diastolic. Q19 [Siting Blood Pressure. SBPA. Visit 1],SBPA19,phs000280.v4.pht004192.v2.phv00210288.v1,phs000280.v8.p2,phv00210288.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210289,ARIC,bp_diastolic_1,[Third blood pressure measurement]. 3rd zero reading. Q20 [Siting Blood Pressure. SBPA. Visit 1],SBPA20,phs000280.v4.pht004192.v2.phv00210289.v1,phs000280.v8.p2,phv00210289.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112481,CARDIA,bp_diastolic_1,SECOND READING SBP,A02R2S,phs000285.v3.pht001560.v2.phv00112481.v2,phs000285.v3.p2,phv00112481.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112482,CARDIA,bp_diastolic_1,SECOND READING DBP,A02R2D,phs000285.v3.pht001560.v2.phv00112482.v2,phs000285.v3.p2,phv00112482.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112483,CARDIA,bp_diastolic_1,RZ2 SBP,A02RZ2S,phs000285.v3.pht001560.v2.phv00112483.v2,phs000285.v3.p2,phv00112483.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112484,CARDIA,bp_diastolic_1,RZ2 DBP,A02RZ2D,phs000285.v3.pht001560.v2.phv00112484.v2,phs000285.v3.p2,phv00112484.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112487,CARDIA,bp_diastolic_1,THIRD READING SBP,A02R3S,phs000285.v3.pht001560.v2.phv00112487.v2,phs000285.v3.p2,phv00112487.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112488,CARDIA,bp_diastolic_1,THIRD READING DBP,A02R3D,phs000285.v3.pht001560.v2.phv00112488.v2,phs000285.v3.p2,phv00112488.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112489,CARDIA,bp_diastolic_1,RZ3 SBP,A02RZ3S,phs000285.v3.pht001560.v2.phv00112489.v2,phs000285.v3.p2,phv00112489.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112490,CARDIA,bp_diastolic_1,RZ3 DBP,A02RZ3D,phs000285.v3.pht001560.v2.phv00112490.v2,phs000285.v3.p2,phv00112490.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00115119,CARDIA,bp_diastolic_1,AGE AT EXAM 1 (VERIFIED AT EXAM 2),EXAMAGE,phs000285.v3.pht001645.v2.phv00115119.v2,phs000285.v3.p2,phv00115119.v2.p2,pht001645.v2.p2,B2REF,CARDIA Cohort
phv00100435,CHS,bp_diastolic_1,AVE ZERO MUD SYSTOL (mm Hg),AVZMSYS,phs000287.v6.pht001452.v1.phv00100435.v1,phs000287.v7.p1,phv00100435.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100436,CHS,bp_diastolic_1,AVE ZERO MUD DIASTOL-adj (mm Hg),AVZMDIA,phs000287.v6.pht001452.v1.phv00100436.v1,phs000287.v7.p1,phv00100436.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,bp_diastolic_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159583,COPDGene,bp_diastolic_1,Diastolic blood pressure [mmHg],diasBP,phs000179.v5.pht002239.v4.phv00159583.v4,phs000179.v6.p2,phv00159583.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159590,COPDGene,bp_diastolic_1,Systolic blood pressure [mmHg],sysBP,phs000179.v5.pht002239.v4.phv00159590.v4,phs000179.v6.p2,phv00159590.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,bp_diastolic_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226251,HCHS_SOL,bp_diastolic_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226390,HCHS_SOL,bp_diastolic_1,Average Systolic (SBPA5),SBPA5,phs000810.v1.pht004715.v1.phv00226390.v1,phs000810.v2.p2,phv00226390.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226391,HCHS_SOL,bp_diastolic_1,Average Diastolic (SBPA6),SBPA6,phs000810.v1.pht004715.v1.phv00226391.v1,phs000810.v2.p2,phv00226391.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00128370,JHS,bp_diastolic_1,"Q13. D. First blood pressure measurement. Systolic (first BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA13,phs000286.v5.pht001974.v1.phv00128370.v1,phs000286.v7.p2,phv00128370.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128371,JHS,bp_diastolic_1,"Q14. D. First blood pressure measurement. Diastolic (first BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA14,phs000286.v5.pht001974.v1.phv00128371.v1,phs000286.v7.p2,phv00128371.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128372,JHS,bp_diastolic_1,"Q15. D. First blood pressure measurement. Zero reading (first BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA15,phs000286.v5.pht001974.v1.phv00128372.v1,phs000286.v7.p2,phv00128372.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128373,JHS,bp_diastolic_1,"Q16. E. Second blood pressure measurement. Systolic (second BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA16,phs000286.v5.pht001974.v1.phv00128373.v1,phs000286.v7.p2,phv00128373.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128374,JHS,bp_diastolic_1,"Q17. E. Second blood pressure measurement. Diastolic (second BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA17,phs000286.v5.pht001974.v1.phv00128374.v1,phs000286.v7.p2,phv00128374.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128375,JHS,bp_diastolic_1,"Q18. E. Second blood pressure measurement. Zero Reading (second BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA18,phs000286.v5.pht001974.v1.phv00128375.v1,phs000286.v7.p2,phv00128375.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,bp_diastolic_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083403,MESA,bp_diastolic_1,SEATED BP: SYSTOLIC 2ND READING (mmHg),s2bp1,phs000209.v13.pht001111.v4.phv00083403.v1,phs000209.v13.p3,phv00083403.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083404,MESA,bp_diastolic_1,SEATED BP: DIASTOLIC 2ND READING (mmHg),d2bp1,phs000209.v13.pht001111.v4.phv00083404.v1,phs000209.v13.p3,phv00083404.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083406,MESA,bp_diastolic_1,SEATED BP: SYSTOLIC 3RD READING (mmHg),s3bp1,phs000209.v13.pht001111.v4.phv00083406.v1,phs000209.v13.p3,phv00083406.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083407,MESA,bp_diastolic_1,SEATED BP: DIASTOLIC 3RD READING (mmHg),d3bp1,phs000209.v13.pht001111.v4.phv00083407.v1,phs000209.v13.p3,phv00083407.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,bp_diastolic_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085735,MESA,bp_diastolic_1,SEATED BP: SYSTOLIC 2ND READING (mmHg),s2bp1,phs000209.v13.pht001116.v10.phv00085735.v2,phs000209.v13.p3,phv00085735.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085736,MESA,bp_diastolic_1,SEATED BP: DIASTOLIC 2ND READING (mmHg),d2bp1,phs000209.v13.pht001116.v10.phv00085736.v2,phs000209.v13.p3,phv00085736.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085737,MESA,bp_diastolic_1,SEATED BP: SYSTOLIC 3RD READING (mmHg),s3bp1,phs000209.v13.pht001116.v10.phv00085737.v2,phs000209.v13.p3,phv00085737.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085738,MESA,bp_diastolic_1,SEATED BP: DIASTOLIC 3RD READING (mmHg),d3bp1,phs000209.v13.pht001116.v10.phv00085738.v2,phs000209.v13.p3,phv00085738.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,bp_diastolic_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087509,MESA,bp_diastolic_1,2ND READING: SEATED SYSTOLIC BP (mmHg),s2bpf,phs000209.v13.pht001121.v3.phv00087509.v1,phs000209.v13.p3,phv00087509.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087510,MESA,bp_diastolic_1,2ND READING: SEATED DIASTOLIC BP (mmHg),d2bpf,phs000209.v13.pht001121.v3.phv00087510.v1,phs000209.v13.p3,phv00087510.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087512,MESA,bp_diastolic_1,3RD READING: SEATED SYSTOLIC BP (mmHg),s3bpf,phs000209.v13.pht001121.v3.phv00087512.v1,phs000209.v13.p3,phv00087512.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087513,MESA,bp_diastolic_1,3RD READING: SEATED DIASTOLIC BP (mmHg),d3bpf,phs000209.v13.pht001121.v3.phv00087513.v1,phs000209.v13.p3,phv00087513.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,bp_diastolic_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,bp_diastolic_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079850,WHI,bp_diastolic_1,Visit Type,F80VTYP,phs000200.v11.pht001019.v6.phv00079850.v6,phs000200.v12.p3,phv00079850.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079852,WHI,bp_diastolic_1,F80 Days since randomization/enrollment,F80DAYS,phs000200.v11.pht001019.v6.phv00079852.v6,phs000200.v12.p3,phv00079852.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079854,WHI,bp_diastolic_1,Systolic blood pressure (1st reading),SYSTBP1,phs000200.v11.pht001019.v6.phv00079854.v6,phs000200.v12.p3,phv00079854.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079855,WHI,bp_diastolic_1,Diastolic blood pressure (1st reading),DIASBP1,phs000200.v11.pht001019.v6.phv00079855.v6,phs000200.v12.p3,phv00079855.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079856,WHI,bp_diastolic_1,Systolic blood pressure (2nd reading),SYSTBP2,phs000200.v11.pht001019.v6.phv00079856.v6,phs000200.v12.p3,phv00079856.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079857,WHI,bp_diastolic_1,Diastolic blood pressure (2nd reading),DIASBP2,phs000200.v11.pht001019.v6.phv00079857.v6,phs000200.v12.p3,phv00079857.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00204712,ARIC,bp_systolic_1,Age at visit 1 [Cohort. Visit 1],V1AGE01,phs000280.v4.pht004063.v2.phv00204712.v1,phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210284,ARIC,bp_systolic_1,[Second blood pressure measurement]. 2nd systolic. Q15 [Siting Blood Pressure. SBPA. Visit 1],SBPA15,phs000280.v4.pht004192.v2.phv00210284.v1,phs000280.v8.p2,phv00210284.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210285,ARIC,bp_systolic_1,[Second blood pressure measurement]. 2nd diastolic. Q16 [Siting Blood Pressure. SBPA. Visit 1],SBPA16,phs000280.v4.pht004192.v2.phv00210285.v1,phs000280.v8.p2,phv00210285.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210286,ARIC,bp_systolic_1,[Second blood pressure measurement]. 2nd zero reading. Q17 [Siting Blood Pressure. SBPA. Visit 1],SBPA17,phs000280.v4.pht004192.v2.phv00210286.v1,phs000280.v8.p2,phv00210286.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210287,ARIC,bp_systolic_1,[Third blood pressure measurement]. 3rd systolic. Q18 [Siting Blood Pressure. SBPA. Visit 1],SBPA18,phs000280.v4.pht004192.v2.phv00210287.v1,phs000280.v8.p2,phv00210287.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210288,ARIC,bp_systolic_1,[Third blood pressure measurement]. 3rd diastolic. Q19 [Siting Blood Pressure. SBPA. Visit 1],SBPA19,phs000280.v4.pht004192.v2.phv00210288.v1,phs000280.v8.p2,phv00210288.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00210289,ARIC,bp_systolic_1,[Third blood pressure measurement]. 3rd zero reading. Q20 [Siting Blood Pressure. SBPA. Visit 1],SBPA20,phs000280.v4.pht004192.v2.phv00210289.v1,phs000280.v8.p2,phv00210289.v2.p2,pht004192.v3.p2,SBPA02,Atherosclerosis Risk in Communities (ARIC) Cohort
phv00112481,CARDIA,bp_systolic_1,SECOND READING SBP,A02R2S,phs000285.v3.pht001560.v2.phv00112481.v2,phs000285.v3.p2,phv00112481.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112482,CARDIA,bp_systolic_1,SECOND READING DBP,A02R2D,phs000285.v3.pht001560.v2.phv00112482.v2,phs000285.v3.p2,phv00112482.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112483,CARDIA,bp_systolic_1,RZ2 SBP,A02RZ2S,phs000285.v3.pht001560.v2.phv00112483.v2,phs000285.v3.p2,phv00112483.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112484,CARDIA,bp_systolic_1,RZ2 DBP,A02RZ2D,phs000285.v3.pht001560.v2.phv00112484.v2,phs000285.v3.p2,phv00112484.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112487,CARDIA,bp_systolic_1,THIRD READING SBP,A02R3S,phs000285.v3.pht001560.v2.phv00112487.v2,phs000285.v3.p2,phv00112487.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112488,CARDIA,bp_systolic_1,THIRD READING DBP,A02R3D,phs000285.v3.pht001560.v2.phv00112488.v2,phs000285.v3.p2,phv00112488.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112489,CARDIA,bp_systolic_1,RZ3 SBP,A02RZ3S,phs000285.v3.pht001560.v2.phv00112489.v2,phs000285.v3.p2,phv00112489.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00112490,CARDIA,bp_systolic_1,RZ3 DBP,A02RZ3D,phs000285.v3.pht001560.v2.phv00112490.v2,phs000285.v3.p2,phv00112490.v2.p2,pht001560.v2.p2,A4F02,CARDIA Cohort
phv00115119,CARDIA,bp_systolic_1,AGE AT EXAM 1 (VERIFIED AT EXAM 2),EXAMAGE,phs000285.v3.pht001645.v2.phv00115119.v2,phs000285.v3.p2,phv00115119.v2.p2,pht001645.v2.p2,B2REF,CARDIA Cohort
phv00100435,CHS,bp_systolic_1,AVE ZERO MUD SYSTOL (mm Hg),AVZMSYS,phs000287.v6.pht001452.v1.phv00100435.v1,phs000287.v7.p1,phv00100435.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100436,CHS,bp_systolic_1,AVE ZERO MUD DIASTOL-adj (mm Hg),AVZMDIA,phs000287.v6.pht001452.v1.phv00100436.v1,phs000287.v7.p1,phv00100436.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00100487,CHS,bp_systolic_1,CALCULATED AGE AT BASELINE,AGEBL,phs000287.v6.pht001452.v1.phv00100487.v1,phs000287.v7.p1,phv00100487.v1.p1,pht001452.v1.p1,BASEBOTH,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older
phv00159583,COPDGene,bp_systolic_1,Diastolic blood pressure [mmHg],diasBP,phs000179.v5.pht002239.v4.phv00159583.v4,phs000179.v6.p2,phv00159583.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159590,COPDGene,bp_systolic_1,Systolic blood pressure [mmHg],sysBP,phs000179.v5.pht002239.v4.phv00159590.v4,phs000179.v6.p2,phv00159590.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00159836,COPDGene,bp_systolic_1,Age at enrollment,Age_Enroll,phs000179.v5.pht002239.v4.phv00159836.v4,phs000179.v6.p2,phv00159836.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,Genetic Epidemiology of COPD (COPDGene)
phv00226251,HCHS_SOL,bp_systolic_1,Age,AGE,phs000810.v1.pht004715.v1.phv00226251.v1,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226390,HCHS_SOL,bp_systolic_1,Average Systolic (SBPA5),SBPA5,phs000810.v1.pht004715.v1.phv00226390.v1,phs000810.v2.p2,phv00226390.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00226391,HCHS_SOL,bp_systolic_1,Average Diastolic (SBPA6),SBPA6,phs000810.v1.pht004715.v1.phv00226391.v1,phs000810.v2.p2,phv00226391.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,Hispanic Community Health Study /Study of Latinos (HCHS/SOL)
phv00128370,JHS,bp_systolic_1,"Q13. D. First blood pressure measurement. Systolic (first BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA13,phs000286.v5.pht001974.v1.phv00128370.v1,phs000286.v7.p2,phv00128370.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128371,JHS,bp_systolic_1,"Q14. D. First blood pressure measurement. Diastolic (first BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA14,phs000286.v5.pht001974.v1.phv00128371.v1,phs000286.v7.p2,phv00128371.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128372,JHS,bp_systolic_1,"Q15. D. First blood pressure measurement. Zero reading (first BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA15,phs000286.v5.pht001974.v1.phv00128372.v1,phs000286.v7.p2,phv00128372.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128373,JHS,bp_systolic_1,"Q16. E. Second blood pressure measurement. Systolic (second BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA16,phs000286.v5.pht001974.v1.phv00128373.v1,phs000286.v7.p2,phv00128373.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128374,JHS,bp_systolic_1,"Q17. E. Second blood pressure measurement. Diastolic (second BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA17,phs000286.v5.pht001974.v1.phv00128374.v1,phs000286.v7.p2,phv00128374.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00128375,JHS,bp_systolic_1,"Q18. E. Second blood pressure measurement. Zero Reading (second BP) [Visit 1] [Sitting Blood Pressure Form, SBP]",SBPA18,phs000286.v5.pht001974.v1.phv00128375.v1,phs000286.v7.p2,phv00128375.v2.p2,pht001974.v2.p2,sbpa,Jackson Heart Study (JHS) Cohort
phv00082639,MESA,bp_systolic_1,AGE,age1c,phs000209.v13.pht001111.v4.phv00082639.v2,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083403,MESA,bp_systolic_1,SEATED BP: SYSTOLIC 2ND READING (mmHg),s2bp1,phs000209.v13.pht001111.v4.phv00083403.v1,phs000209.v13.p3,phv00083403.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083404,MESA,bp_systolic_1,SEATED BP: DIASTOLIC 2ND READING (mmHg),d2bp1,phs000209.v13.pht001111.v4.phv00083404.v1,phs000209.v13.p3,phv00083404.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083406,MESA,bp_systolic_1,SEATED BP: SYSTOLIC 3RD READING (mmHg),s3bp1,phs000209.v13.pht001111.v4.phv00083406.v1,phs000209.v13.p3,phv00083406.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00083407,MESA,bp_systolic_1,SEATED BP: DIASTOLIC 3RD READING (mmHg),d3bp1,phs000209.v13.pht001111.v4.phv00083407.v1,phs000209.v13.p3,phv00083407.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00084442,MESA,bp_systolic_1,AGE,age1c,phs000209.v13.pht001116.v10.phv00084442.v3,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085735,MESA,bp_systolic_1,SEATED BP: SYSTOLIC 2ND READING (mmHg),s2bp1,phs000209.v13.pht001116.v10.phv00085735.v2,phs000209.v13.p3,phv00085735.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085736,MESA,bp_systolic_1,SEATED BP: DIASTOLIC 2ND READING (mmHg),d2bp1,phs000209.v13.pht001116.v10.phv00085736.v2,phs000209.v13.p3,phv00085736.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085737,MESA,bp_systolic_1,SEATED BP: SYSTOLIC 3RD READING (mmHg),s3bp1,phs000209.v13.pht001116.v10.phv00085737.v2,phs000209.v13.p3,phv00085737.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00085738,MESA,bp_systolic_1,SEATED BP: DIASTOLIC 3RD READING (mmHg),d3bp1,phs000209.v13.pht001116.v10.phv00085738.v2,phs000209.v13.p3,phv00085738.v2.p3,pht001116.v10.p3,MESA_Exam1Main,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087071,MESA,bp_systolic_1,AGE,agefc,phs000209.v13.pht001121.v3.phv00087071.v1,phs000209.v13.p3,phv00087071.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087509,MESA,bp_systolic_1,2ND READING: SEATED SYSTOLIC BP (mmHg),s2bpf,phs000209.v13.pht001121.v3.phv00087509.v1,phs000209.v13.p3,phv00087509.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087510,MESA,bp_systolic_1,2ND READING: SEATED DIASTOLIC BP (mmHg),d2bpf,phs000209.v13.pht001121.v3.phv00087510.v1,phs000209.v13.p3,phv00087510.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087512,MESA,bp_systolic_1,3RD READING: SEATED SYSTOLIC BP (mmHg),s3bpf,phs000209.v13.pht001121.v3.phv00087512.v1,phs000209.v13.p3,phv00087512.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00087513,MESA,bp_systolic_1,3RD READING: SEATED DIASTOLIC BP (mmHg),d3bpf,phs000209.v13.pht001121.v3.phv00087513.v1,phs000209.v13.p3,phv00087513.v1.p3,pht001121.v3.p3,MESA_FamilyExamMain,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort
phv00078436,WHI,bp_systolic_1,F2 Days since randomization,F2DAYS,phs000200.v11.pht000998.v6.phv00078436.v6,phs000200.v12.p3,phv00078436.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00078437,WHI,bp_systolic_1,Age at screening,AGE,phs000200.v11.pht000998.v6.phv00078437.v6,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,Women's Health Initiative
phv00079850,WHI,bp_systolic_1,Visit Type,F80VTYP,phs000200.v11.pht001019.v6.phv00079850.v6,phs000200.v12.p3,phv00079850.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079852,WHI,bp_systolic_1,F80 Days since randomization/enrollment,F80DAYS,phs000200.v11.pht001019.v6.phv00079852.v6,phs000200.v12.p3,phv00079852.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079854,WHI,bp_systolic_1,Systolic blood pressure (1st reading),SYSTBP1,phs000200.v11.pht001019.v6.phv00079854.v6,phs000200.v12.p3,phv00079854.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079855,WHI,bp_systolic_1,Diastolic blood pressure (1st reading),DIASBP1,phs000200.v11.pht001019.v6.phv00079855.v6,phs000200.v12.p3,phv00079855.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079856,WHI,bp_systolic_1,Systolic blood pressure (2nd reading),SYSTBP2,phs000200.v11.pht001019.v6.phv00079856.v6,phs000200.v12.p3,phv00079856.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
phv00079857,WHI,bp_systolic_1,Diastolic blood pressure (2nd reading),DIASBP2,phs000200.v11.pht001019.v6.phv00079857.v6,phs000200.v12.p3,phv00079857.v6.p3,pht001019.v6.p3,f80_rel1,Women's Health Initiative
